[{"id": "5529", "aimg": "1430", "awall": "\nNocardia\u9769\u862d\u6c0f\u967d\u6027\u597d\u6c27\u83cc\u7d30\u80de\u58c1\u542b\u6709 mycolic acid\uff0c\u56e0\u6b64 acid fast stain \u53ef\u4ee5\u5fae\u5fae\u67d3\u4e0a\u9020\u6210\u80ba\u708e\u3001\u8166\u81bf\u760d\u3001\u76ae\u819a\u83cc\u8db3\u816b\uff08mycetoma\uff09\u4ee5 trimethoprim/sulfamethoxazole \u6cbb\u7642\n"}, {"id": "5530", "aimg": "931", "awall": "\nA B C \u6291\u5236\u7d30\u80de\u58c1\u88fd\u9020Mycoplasma \u7121 \u7d30\u80de\u58c1\n"}, {"id": "5531", "aimg": "0", "awall": "\n(A) \u582a\u85a9\u65af\u5206\u679d\u687f\u83cc\u5728 Runyon \u5206\u985e\u6cd5\u4e2d\u5c6c\u65bc Group I \u6162\u751f\u9577\u5149\u7522\u8272\u83cc(slowgrowing photochromogens)\uff0c\u4f3a\u6a5f\u6027\u611f\u67d3\uff0c\u53ef\u80fd\u5c0e\u81f4\u80ba\u7d50\u6838\u3002\u6cbb\u7642\u7528 INH\u3001 rifampin \u548c Ethambutol\u3002\u00a0(B)\u9ce5\u578b\u5206\u679d\u687f\u83cc(Mycobacterium avium)\u662f\u4f3a\u6a5f\u6027\u611f\u67d3\u83cc\uff0c\u5e38\u898b\u65bc\u514d\u75ab\u4e0d\u5168\u7684 \u75c5\u4eba(\u5982\u611b\u6ecb\u75c5)\uff0c\u4f46\u4e5f\u6703\u51fa\u73fe\u65bc\u6162\u6027\u80ba\u75be\u75c5\uff0c\u5982\u652f\u6c23\u7ba1\u64f4\u5f35(bronchiectasis)\u3002\u00a0(C) \u6d77\u6d0b\u5206\u679d\u687f\u83cc(M. marinum)\u5c6c\u65bc Group I \u6162\u751f\u9577\u5149\u7522\u8272\u83cc(slow-growing photochromogens)\uff0c\u85c9\u7531\u76ae\u819a\u611f\u67d3(Cutaneous infection)\uff0c\u597d\u751f\u9577\u65bc\u4f4e\u6eab (30\u00b0C\uff0c\u76f8\u8f03\u65bc\u4eba\u9ad4)\uff0c\u7522\u751f\u7684\u75be\u75c5\u70ba swimming pool granuloma(\u6cf3\u6c60\u8089\u82bd\u816b)\u00a0(D)\u725b\u578b\u5206\u679d\u687f\u83cc(M. bovis)\u53ef\u5c0e\u81f4\u725b\u7d50\u6838\u75c5(bovine tuberculosis\uff0c\u4f3c\u4eba\u7d50\u6838\u75c5)\uff0c \u4e0d\u6703\u6709\u4eba\u50b3\u4eba\u7684\u73fe\u8c61\uff0c\u5176\u6e1b\u6bd2\u682a\u53ef\u88fd\u6210\u5361\u4ecb\u82d7\u3002 \n"}, {"id": "5532", "aimg": "0", "awall": "\nUTI\u3001\u8179\u819c\u708e\u3001\u5fc3\u5167\u819c\u708e\u662f \u8178\u7403\u83cc\u7684\u5e38\u898b\u75c7\u72c0 (\u98df\u7269\u4e2d\u6bd2\u662f\u8461\u8404\u7403\u83cc\u5e38\u898b)\n"}, {"id": "5533", "aimg": "0", "awall": "\nS. pyogenes (\u5c6c\u65bc Group A Streptococci)\u4e3b\u8981\u5f15\u8d77\u5169\u985e\u75be\u75c5\uff1a1\u3001\u5316\u81bf\u6027\u75be\u75c5(\u6bd2\u7d20\u5f15\u8d77)\uff1a\u5982\u54bd\u708e\u3001\u81bf\u76ae\u75c7(Pyoderma)\u3001\u7329\u7d05\u71b1(Scarlet fever)\u3001\u8702\u7aa9\u6027\u7d44\u7e54\u708e\u3001\u58de\u6b7b\u6027\u7b4b\u819c\u708e\u53ca\u4e39\u6bd2\u3002\u00a0\u5316\u81bf\u6027\u75be\u75c5(\u5982\u81bf\u76ae\u75c7)\u7531\u6bd2\u7d20\u76f4\u63a5\u5f15\u8d77\uff0c\u4e0d\u6703\u6e2c\u5230\u9ad8\u6548\u50f9\u7684 ASO \u6297\u9ad42\u3001\u975e\u5316\u81bf\u6027(\u6297\u9ad4\u5a92\u4ecb\u578b)\uff1a\u4f8b\u5982\u98a8\u6fd5\u71b1(rheumatic fever)\u3001\u6025\u6027\u814e\u7d72\u7403\u814e\u708e\u7b49\u3002ASO test \u53ef\u7528\u4ee5\u8a3a\u65b7\u98a8\u6fd5\u71b1\u8207\u6025\u6027\u814e\u7d72\u7403\u814e\u708e\u3002Pyoderma\u7684\u75c5\u60a3\u61c9\u8a72\u4e0d\u6703\u7522\u751f\u592a\u591aASO\u3002\u4e00\u500b\u76f8\u95dc\u7684\u8003\u9ede\u662f\uff0crheumatic fever\u901a\u5e38\u53ea\u6703\u767c\u751f\u5728\u93c8\u7403\u83cc\u7684\u54bd\u5589\u611f\u67d3\u5f8c\u800c\u4e0d\u6703\u767c\u751f\u5728\u76ae\u819a\u611f\u67d3\u5f8c\u3002Group A streptococci \u6703\u7522\u751f\u5169\u985e\u6eb6\u8840\u7d20\uff0c\u4e00\u985e\u662f\u5c0d\u6c27\u6c23\u654f\u611f\u7684 streptolysin O\uff0c\u5177\u6709\u6297\u539f\u6027\uff0c\u53ef\u5f15\u8d77\u6297\u9ad4\u7522\u751f;\u53e6\u4e00\u985e\u662f\u5c0d\u6c27\u6c23\u4e0d\u654f\u611f\u7684 streptolysin S\u3002\n"}, {"id": "5534", "aimg": "0", "awall": "\nC5a peptidase \u662f\u5316\u81bf\u6027\u93c8\u7403\u83cc\u7684\u6771\u897f\uff0c\u7834\u58de\u88dc\u9ad4C5a\uff0c\u4f7f\u5176\u5931\u6548\u3002\n"}, {"id": "5535", "aimg": "2728", "awall": "\n\u6162\u901f\u751f\u9577\uff1a\u7d50\u6838\u5206\u679d\u687f\u83cc\u3001MAC (mycobacterium avium complex) \u7b49\u7b49\u5feb\u901f\u751f\u9577\uff1aM. chelonae, M. fortuitum, M. abscessus \u5c31\u9019\u4e09\u500b\uff0c\u80cc\uff01\n"}, {"id": "5536", "aimg": "2729", "awall": "\nEB-VCA IgM\u00a0\uff1a\u611f\u67d3\u5f8c\u4e0d\u4e45\u3001\u75c7\u72c0\u5c1a\u672a\u51fa\u73fe\u6642\u5c31\u6709\u4e86\uff0c\u4e26\u5728 4 ~ 6 \u9031\u5f8c\u6d88\u5931\uff0c\u5c6c\u65bc\u521d\u6b21\u611f\u67d3\u7684\u6025\u6027\u671f\u6307\u6a19\u3002EB-VCA IgG \uff1a\u611f\u67d3\u5f8c\u4e0d\u4e45\u3001\u75c7\u72c0\u5c1a\u672a\u51fa\u73fe\u6642\u5c31\u6709\u4e86\uff0c\u4e26\u5728 2 ~ 4 \u9031\u6548\u50f9\u9054\u5230\u6700\u9ad8\u9ede\uff0c\u800c\u5f8c\u9010\u6f38\u4e0b\u964d\u4e26\u6301\u7e8c\u7d42\u8eab\u3002EBEA IgG \uff1a\u5c6c\u65bc\u6025\u6027\u671f\u6297\u9ad4\uff0c\u51fa\u73fe\u6642\u9593\u7a0d\u665a\u65bc\u4e0a\u9762\u5169\u8005\uff0c\u5728\u611f\u67d3\u5f8c 3 ~ 6 \u500b\u6708\u6d88\u5931\uff0c\u5fa9\u767c\u611f\u67d3\u6642\u53ef\u80fd\u6703\u518d\u5ea6\u51fa\u73fe\u3002EBNA IgG \uff1a\u5c6c\u65bc\u6062\u5fa9\u671f\u624d\u51fa\u73fe\u7684\u6297\u9ad4\uff0c\u611f\u67d3\u5f8c 2 ~ 4 \u500b\u6708\u624d\u51fa\u73fe\uff0c\u51fa\u73fe\u5f8c\u4ee5\u9ad8\u6548\u50f9\u6301\u7e8c\u7d42\u8eab\u3002[\u5224\u8b80]\uff1a\u56db\u7a2e\u611f\u67d3\u72c0\u614b\u8207\u56db\u7a2e\u6297\u9ad4\u7684\u95dc\u4fc2(\u4e00) \u60a3\u8005\u672a\u66fe\u611f\u67d3 EBV:EB-VCA IgG \u9670\u6027\uff0c\u5373\u4ee3\u8868\u672a\u66fe\u611f\u67d3 EBV\u3002(EBNA IgG \u4ea6\u70ba\u9670\u6027)(\u4e8c) \u60a3\u8005\u8fd1\u671f\u611f\u67d3\u00a0EBV:EB-VCA IgM \u967d\u6027\uff0cEB-VCA IgG \u5f37\u967d\u6027\uff0c EBNA IgG \u9670\u6027\u3002(\u901a\u5e38 EBEA IgG \u4e5f\u6703\u662f\u967d\u6027)(\u4e09) \u60a3\u8005\u5728\u904e\u53bb\u66fe\u7d93\u611f\u67d3 EBV:EB-VCA IgG \u967d\u6027\uff0cEBNA IgG \u967d\u6027\u3002(\u901a\u5e38 EBEA IgG \u662f\u9670\u6027)(\u56db) \u60a3\u8005\u904e\u53bb\u66fe\u7d93\u611f\u67d3,\u76ee\u524d\u75c5\u6bd2\u53c8\u518d\u5ea6\u6d3b\u5316,\u5fa9\u767c\u611f\u67d3:EBEA IgG \u967d\u6027\uff0cEBNA IgG \u4ea6\u967d\u6027\u3002(EB-VCA IgG \u4ea6\u70ba\u967d\u6027)\n"}, {"id": "5537", "aimg": "2730", "awall": "\n5 Groups of Anti-Retroviral drug\u00a0- Fusion inhibitor- Nucleoside reverse transcriptase inhibitor (NRTI)- Non-nucleoside reverse transcriptase inhibitor (NNRTI)- Integrase inhibitor- Protease inhibitor\u00a0\n"}, {"id": "5538", "aimg": "2731", "awall": "\n\u8f2a\u5230\u65e5\u672cMMR\u53bb\u9ec3\u6cb3\u73a9\u6c34\u559d\u51b0\u6c99\u8f2a\u72c0\u3001\u65e5\u672c\u8166\u708e\u3001MMR(\u9ebb\u75b9\u3001\u816e\u817a\u708e\u3001\u5fb7\u570b\u9ebb\u75b9)\u3001\u9ec3\u71b1\u75c5\u3001\u6c34\u75d8\u3001\u6c99\u8cd3\n"}, {"id": "5539", "aimg": "0", "awall": "\n\u5148\u5929\u6027\u611f\u67d3\uff34\uff2f\uff32\uff23\uff28T:\u5f13\u5f62\u87f2(Toxoplasma gondii)\uff1a\u8108\u7d61\u819c\u8996\u7db2\u819c\u708e\u3001\u6c34\u8166\u3001\u9871\u5167\u9223\u5316O:\u5176\u4ed6(Others)\uff1a\u6885\u6bd2\u3001HIV\u3001Parvovirus B19\u3001\u8178\u75c5\u6bd2\u3001VZV\u3001ZikaR:\u5fb7\u570b\u9ebb\u75b9(Rubella)\uff1a\u611f\u97f3\u795e\u7d93\u6027\u8033\u807e\u3001\u767d\u5167\u969c\u3001\u5fc3\u81df\u7578\u5f62\u3001\u751f\u9577\u9072\u7de9\u3001\u667a\u80fd\u969c\u7919\u3001\u9aa8\u9abc\u3001\u809d\u81df\u3001\u813e\u81df\u7b49\u9577\u671f\u640d\u5bb3C:\u5de8\u7d30\u80de\u75c5\u6bd2(Cytomegalovirus)\uff1a\u8108\u7d61\u819c\u8996\u7db2\u819c\u708e\u3001\u611f\u97f3\u795e\u7d93\u6027\u8033\u807e\u3001\u5f71\u97ff\u795e\u7d93\u767c\u80b2(\u667a\u80fd\u969c\u7919\u3001\u5c0f\u8166\u75c7\u3001\u904b\u52d5\u969c\u7919\u3001\u8166\u9223\u5316\u3001\u7672\u7647)H:\u55ae\u7d14\u76b0\u75b9\u75c5\u6bd2 (Herpes Simplex Virus)\uff1a\u9ad8\u71b1\u3001\u547c\u5438\u56f0\u96e3\u3001CNS \u75c5\u8b8a\n"}, {"id": "5540", "aimg": "0", "awall": "\n\u8207\u96f7\u6c0f\u75c7\u5019\u7fa4\u76f8\u95dc\u6027\u9ad8\u7684\u75c5\u6bd2\uff1a\u6c34\u75d8\u3001\u6d41\u611f\u3001\u767b\u9769\u71b1\u3010\u53e3\u8a23\u3011\u6253\u96f7\u7684\u6642\u5019\uff0c\u6c34\u9762\u4e0a\u6709\u6d41\u52d5\u7684\u71c8\u5149\u5152\u7ae5 + influenza + asprin = Reye syndrome\u80cc\u8d77\u4f86\n"}, {"id": "5541", "aimg": "0", "awall": "\n(A)\u00a0Sindbis virus:\u5c6c\u65bc Togaviridae\uff0c\u662f\u55ae\u80a1 positive-sense \u7684 RNA \u5305\u819c\u75c5\u6bd2\u3002 \u5929\u7136\u5bbf\u4e3b\u70ba\u868a\u5b50\u8207\u9ce5\u985e\u3002\u5927\u90e8\u5206\u7684\u6848\u4f8b\u767c\u751f\u5728\u5317\u6b50\uff0c\u4e14\u6703\u6709\u9593\u6b47\u6027\u5927\u7206\u767c(\u5728 \u82ac\u862d\uff0c\u6bcf\u4e03\u5e74\u6703\u4e00\u6b21\u5927\u7206\u767c)(B) \u00a0Semliki Forest virus:\u5c6c\u65bc Togaviridae\uff0c\u662f\u55ae\u80a1 positive-sense \u7684 RNA \u5305\u819c \u75c5\u6bd2\u3002\u5bbf\u4e3b\u70ba\u9ce5\u985e\u3001\u5699\u9f52\u985e\u3001\u9748\u9577\u985e\u3002(C) \u00a0West Nile encephalitis virus:\u5c6c\u65bc Flaviviridae\uff0c\u662f\u55ae\u80a1 positive-sense \u7684 RNA \u5305\u819c\u75c5\u6bd2\u3002\u5176\u5929\u7136\u5bbf\u4e3b\u70ba\u9ce5\u985e\u3002\u4eba\u985e\u900f\u904e\u88ab\u868a\u5b50\u53ee\u54ac\u800c\u611f\u67d3\uff0c\u53ef\u80fd\u6703\u51fa\u73fe \u81f4\u547d\u7684\u795e\u7d93\u75c7\u72c0\uff0c\u4f46\u662f\u7d04 80%\u7684\u4eba\u611f\u67d3\u5f8c\u4e0d\u6703\u6709\u4efb\u4f55\u75c7\u72c0\u3002(D)Chikungunya virus:\u5c6c\u65bc Togaviridae\uff0c\u662f\u55ae\u80a1 positive-sense \u7684 RNA \u5305\u819c \u75c5\u6bd2\u3002\u5176\u6700\u4e3b\u8981\u7684\u5929\u7136\u5bbf\u4e3b\u5c31\u662f\u4eba\u985e\uff0c\u800c\u5728\u975e\u6d32\u6709\u767c\u73fe\u88ab\u6591\u868a\u53ee\u54ac\u7684\u9748\u9577\u985e\u4e5f \u662f\u5929\u7136\u5bbf\u4e3b\u3002Toga:\u5c48\u516cFlavi:\u767b\u9769\u3001\u9ec3\u71b1\u3001\u8332\u5361\n"}, {"id": "5542", "aimg": "0", "awall": "\n\u82b1\u6591\u766c(Pityriasis versicolor)\u5c31\u662f\u4fd7\u7a31\u7684\u6c57\u73ed\uff0c\u81f4\u75c5\u539f\u662f\u7c83\u7ce0\u99ac\u62c9\u8272\u83cc\u7d9c\u5408\u83cc (Malassezia furfur complex)\uff0c\u662f\u5e38\u898b\u7684\u8868\u76ae\u771f\u83cc\u611f\u67d3\u8a3a\u65b7\u3000\u3000\u6839\u64da\u5178\u578b\u7684\u81e8\u5e8a\u8868\u73fe\uff0c\u522e\u53d6\u76ae\u5c51\uff0c\u52a0\u5165KOH\u6eb6\u6db2\u4e2d\u3001\u52a0\u71b1\uff0c\u7136\u5f8c\u505a\u771f\u83cc\u76f4\u63a5\u93e1\u6aa2\uff0c\u53ef\u898b\u5f4e\u66f2\u83cc\u548c\u5713\u5f62\u539a\u58c1\u5b62\u5b50\uff0c\u4ee5\u53ca\u76ae\u819a\u5728\u4f0d\u6c0f\u71c8\u6aa2\u67e5\u4e0b\u5448\u85cd\u7da0\u8272\u87a2\u5149\uff0c\u5373\u53ef\u78ba\u8a3a\u3002\u93e1\u6aa2\u660e\u986f\u770b\u5230\"spaghetti and meatballs\"\u7684\u5f62\u72c0Malassezia\u662f\u4eba\u9ad4\u8868\u76ae\u7684\u6b63\u5e38\u83cc\u53e2\uff0c\u5728\u6b63\u5e38\u4eba\u76ae\u819a\u4e0a\u5448\u73fe yeast form\uff0c\u5728\u63a5\u89f8\u6f6e\u6fd5\u7684\u5929\u6c23\u5f8c\uff0c\u53ef\u80fd\u6703\u8f49\u8b8a\u6210\u5177\u81f4\u75c5\u6027\u7684 mycelial form\u3002\u800c\u8150\u751f\u83cc\u6307\u7684\u662f\u5f9e\u5df2\u6b7b\u7684\u52d5\u690d\u7269\u5438\u53d6\u990a\u5206\u7684\u771f\u83cc\uff0c\u8207\u984c\u76ee\u7684 Malassezia \u4e0d\u5408\u3002\u76db\u884c\u5340\u57df\u4ee5\u71b1\u5e36\u570b\u5bb6\u70ba\u4e3b\uff0c\u5e38\u898b\u65bc\u5e74\u8f15\u4eba\u8207\u6210\u4eba\u3002\n"}, {"id": "5543", "aimg": "0", "awall": "\n\u5236\u9ef4\u83cc\u7d20(Nystatin)\uff1a\u7d50\u5408\u5230\u771f\u83cc\u7d30\u80de\u819c\u7684 ergosterol\uff0c\u9020\u6210\u7d30\u80de\u819c\u7834\u88c2(A) \u6c1f\u80de\u5627\u5576(Flucytosine)\uff1a\u6d3b\u5316\u70ba 5-Fluorouracil (5-FU)\u6291\u5236 DNA \u8207 RNA \u5408\u6210(B)\u5169\u6027\u9ef4\u7d20(Amphotericin B)\uff1a\u7d50\u5408\u771f\u83cc\u7d30\u80de\u819c\u7684 ergosterol(C) \u5361\u6cca\u82ac\u6de8(Caspofungin)\uff1a\u5f71\u97ff\u7d30\u80de\u58c1\u5408\u6210(D)\u7cde\u6bbc\u83cc\u7d20(Sordarin)\uff1a\u6703\u7d50\u5408 EF2 \u4f7f\u5176\u5931\u53bb\u6d3b\u6027\uff0c\u5f71\u97ff\u86cb\u767d\u8cea\u5408\u6210\n"}, {"id": "5544", "aimg": "2737", "awall": "\n1. HIV \u7684\u85e5\u7269\u6709\u4e94\u5927\u5206\u985e:\u5206\u985e\u6a5f\u5236\u85e5\u7269NRTI (nucleoside RT inhibitor)\u7af6\u722d\u6027\u6291\u5236 reverse transcriptase\u00a0Zidovudine (AZT) Stavudine (d4T) Didanosine (ddI)...NNRTI (non-nucleoside RT inhibitor)\u7d50\u5408 reverse transcriptase \u800c \u6291\u5236\u8f49\u9304Etravirine (ETR) Rilpivirine (RPV)...Protease inhibitor\u6291\u5236\u75c5\u6bd2\u8655\u7406\u8f49\u9304\u51fa\u7684\u86cb\u767dIndinavir (IDV)...HIV entry inhibitor\u6291\u5236\u75c5\u6bd2\u9032\u5165\u5bbf\u4e3b\u7d30\u80deEnfuvirtide MaravirocIntegrase inhibitor\u6291\u5236\u75c5\u6bd2 genome \u5d4c\u5165\u5bbf\u4e3b genomeRaltegravir...2. HIV \u75c5\u6bd2\u7684 genome \u5305\u62ec:(\u4e0d\u53ea\u9019\u4e9b\uff0c\u9019\u88e1\u50c5\u5217\u51fa\u672c\u984c\u9078\u9805)\u5206\u985e\u57fa\u56e0\u7522\u751f\u7684\u86cb\u767d\u7d50\u69cb\u86cb\u767dgag\u5408\u6210\u8863\u6bbc\u7684\u86cb\u767d\u8ceaCapsid protein:\u5305\u62ec p17\u3001p24\u3001p7\u3001p6 \u7b49\u86cb\u767d\u3002pol\u5408\u6210\u53cd\u8f49\u9304\u9176 \u86cb\u767d\u9176\u9175\u7d20:\u5305\u62ec protease\u3001reverse transcriptase\u3001 integrase\u3002env\u5f62\u6210\u5916\u5957\u819c\u7684\u86cb\u767d\u8ceaEnvelope \u4e0a\u7684\u86cb\u767d:\u5305\u62ec gp120 \u548c gp41\uff0c\u4f5c\u7528\u70ba\u63a5\u5408\u5bbf\u4e3b \u7d30\u80de\u4e0a\u7684 receptor\u3002\u8abf\u63a7\u86cb\u767dtat\u6297\u7d42\u6b62\u86cb\u767d:\u4f7f HIV \u7684\u57fa\u56e0\u80fd\u6709\u6548\u8868\u9054\u3002\n"}, {"id": "5545", "aimg": "2738", "awall": "\n\u771f\u83cc\u7684\u7121\u6027\u5b62\u5b50\u5206\u70ba conidia \u548c sporangiospores \u5169\u5927\u985e\n"}, {"id": "5546", "aimg": "0", "awall": "\n\u76ee\u524d\u9084\u6c92\u6709\u8a73\u89e3\u3002\n"}, {"id": "5547", "aimg": "0", "awall": "\nGM-CSF, IL-4, IFN-a \u7686\u6703\u523a\u6fc0\u55ae\u6838\u7403\u5206\u5316\u6210\u6a39\u7a81\u7d30\u80de (M-CSF \u662f\u5206\u5316\u6210\u5de8\u566c\u7d30\u80de)\n"}, {"id": "5548", "aimg": "0", "awall": "\nB \u7d30\u80de\u7684\u6210\u719f\u904e\u7a0b\uff1a1. class switch(\u85c9\u7531\u57fa\u56e0\u91cd\u7d44) \u2b05\ufe0f \u61c9\u8a72\u662fRNA splicing (\u4e0d\u540cisotope)\uff0cgene rearrangement \u5728VDJ\u91cd\u7d44\uff08\u4e0d\u540cIdiotype)2. somatic hypermutation\uff08\u4f8b\u5b50\uff1aaffinity maturation)3. IgM. IgD expression on surface(\u85c9\u7531 RNA splicing)4. membrane form/ secretion form(\u85c9\u7531 RNA splicing)\n"}, {"id": "5549", "aimg": "0", "awall": "\npreTCR\u662f\u7531TCR \u03b2 chain + preT\u03b1 chain \u7d44\u5408\u800c\u6210\n"}, {"id": "5550", "aimg": "0", "awall": "\n(A)\u00a0\u8a31\u591a\u816b\u7624\u7d30\u80de\u6703\u5206\u6ccc TGF-\u03b2\uff0c\u4f7f\u9032\u5165\u816b\u7624 microenvironment \u7684 CD4+\u00a0T \u7d30\u80de \u589e\u52a0\u8f49\u9304\u56e0\u5b50 FoxP3 \u7684\u8868\u73fe\uff0c\u9032\u800c\u5206\u5316\u6210 Treg \u7d30\u80de\uff0c\u6291\u5236\u514d\u75ab\u7cfb\u7d71\u5c0d\u816b\u7624\u7684 \u653b\u64ca\u3002(B)Treg \u7d30\u80de\u529f\u80fd\u4f4e\u4e0b\u624d\u6703\u9020\u6210\u81ea\u9ad4\u514d\u75ab\u75be\u75c5\u767c\u75c5\uff0c\u529f\u80fd\u904e\u5ea6\u6d3b\u5316\u6703\u9020\u6210\u8eab\u9ad4\u5c0d \u816b\u7624\u8207\u75c5\u83cc\u7684\u62b5\u6297\u529b\u4e0b\u964d\u3002(C) Treg \u7d30\u80de\u4e5f\u53ef\u4ee5\u5728\u80f8\u817a\u5206\u5316(\u570b\u8003\u89e3\u984c\u89c0\u5ff5:\u770b\u5230\u300c\u90fd\u300d\u5c31\u8981\u6709\u8b66\u89ba\u5fc3\u4e86)\u00a0(D) Treg \u7d30\u80de\u662f\u7531 CD4+ T \u7d30\u80de\u5206\u5316\u4f86\u7684\n"}, {"id": "5551", "aimg": "2754", "awall": "\nTFH \u7d30\u80de\u7684\u529f\u80fd\u70ba\u4fc3\u9032\u6f3f\u7d30\u80de\u5206\u5316(\u53ef\u5206\u6ccc IL-21)\uff0c\u4f46\u5c0d\u65bc IgG1 \u6297\u9ad4\u7522\u751f\u7121\u76f4\u63a5\u5f71\u97ff (\u61c9\u8a72\u52a0\u5165 IL-4 )\uff1b\u4e3b\u8981\u5b58\u5728 light zone\u8ca0\u8cac\u5438\u5f15\u66f4\u591a B \u7d30\u80de\u7559\u5728 germinal center\u3001\u5e6b\u52a9 B \u7d30\u80de\u5206\u5316\u70ba\u6f3f\u7d30\u80de\u8207 class switching\uff0c\u4e5f\u6703\u5206\u6cccIL-21\u523a\u6fc0Plasma cell\u5206\u5316\u3002\u8f49\u9304\u56e0\u5b50 Bcl-6 \u7684\u8868\u73fe\u91cf\u589e\u52a0\u4f7f CD4+T \u7d30\u80de\u5206\u5316\u70ba TFH \u7d30\u80de\u8a73\u89e3(A) \u00a0\u6b63\u78ba\u3002TFH \u4e3b\u8981\u662f\u5728 light zone\uff0c\u8ca0\u8cac\u5438\u5f15\u66f4\u591a B \u7d30\u80de\u7559\u5728 germinal center\u3001 \u5e6b\u52a9 B \u7d30\u80de\u5206\u5316\u70ba\u6f3f\u7d30\u80de\u8207 class switching(B) \u00a0\u6b63\u78ba\u3002\u8f49\u9304\u56e0\u5b50 Bcl-6 \u7684\u8868\u73fe\u91cf\u589e\u52a0\u624d\u6703\u4f7f CD4+ T \u7d30\u80de\u5206\u5316\u70ba TFH \u7d30\u80de\u3002(C) \u00a0\u6b63\u78ba\u3002TFH \u5206\u6ccc\u7684 IL-21 \u53ef\u4fc3\u4f7f\u6f3f\u7d30\u80de\u5206\u5316\u3002(D) \u00a0\u932f\u8aa4\u3002\u55ae\u7368\u52a0\u5165 LPS \u53ef\u4fc3\u4f7f B \u7d30\u80de\u7522\u751f IgG2 \u8207 IgG3\uff0c\u9808\u518d\u52a0\u5165 IL-4 \u624d\u80fd\u4f7f B\u7d30\u80de\u6539\u70ba\u7522\u751f IgG1\u3002IL-21 \u9664\u4e86\u53ef\u4ee5\u4f7f\u6f3f\u7d30\u80de\u5206\u5316\uff0c\u4e5f\u8207\u4fc3\u9032 B \u7d30\u80de\u7522\u751f IgG1, IgG3, IgA \u6709\u95dc;\u7576 IL-21 \u8207 IL-4 \u540c\u6642\u52a0\u5165\u6642\uff0c\u6703\u56e0\u5354\u540c\u4f5c\u7528\u589e\u52a0 IgG1 \u7684\u7522\u91cf\uff0c \u800c\u4e14 IL-21 \u4fc3\u9032 IgG3, IgA \u7522\u751f\u7684\u6548\u679c\u6703\u88ab IL-4 \u6291\u5236\u3002IL-2 \u662f T \u7d30\u80de\u751f\u9577\u56e0\u5b50\uff0c \u4e3b\u8981\u662f\u4fc3\u9032 TH1 \u53cd\u61c9\uff0c\u8207\u6297\u9ad4\u7522\u751f\u8f03\u7121\u95dc\u3002\u88dc\u5145\u8aaa\u660e\u70ba\u4ec0\u9ebc\u9700\u8981\u52a0\u5165 LPS:\u4e00\u822c\u4f86\u8aaa B \u7d30\u80de\u5728\u8fa8\u8b58\u6297\u539f\u5f8c\uff0c\u9084\u9700\u8981\u5c07\u6297\u539f\u5448\u73fe\u7d66 TFH\u00a0\u7d30\u80de\uff0c\u4e26\u85c9\u7531 CD40 \u8207 TFH\u00a0\u4e0a\u7684 CD40L \u7d50\u5408\u624d\u80fd\u9806\u5229\u6d3b\u5316;\u7136\u800c\uff0c\u6709\u4e9b\u6297\u539f\u672c\u8eab\u5c31\u53ef\u4ee5\u8a98\u767c B \u7d30\u80de\u7522\u751f \u6297\u9ad4\uff0c\u4e0d\u9808\u501a\u8cf4 T \u7d30\u80de\u7684\u5e6b\u52a9\uff0c\u7a31\u70ba thymus-independent (TI) antigen\uff0c\u800c LPS \u5c31\u662f\u5176\u4e2d\u4e00\u7a2e TI antigen\uff0c\u56e0\u6b64\u53ef\u4ee5\u5728\u7f3a\u4e4f T \u7d30\u80de\u7684\u9ad4\u5916\u57f9\u990a\u74b0\u5883\u4e0b\u4fc3\u4f7f B \u7d30\u80de \u7522\u751f\u6297\u9ad4\u3002\n"}, {"id": "5552", "aimg": "0", "awall": "\n\u7528\u4f60\u7684\u8178\u5b50\u601d\u8003\n"}, {"id": "5553", "aimg": "2755", "awall": "\n\u4ee5 caseating granuloma \u70ba\u4f8b\n"}, {"id": "5554", "aimg": "1295", "awall": "\n\n"}, {"id": "5555", "aimg": "0", "awall": "\nCorticosteroids cause immunosuppression mainly by sequestration of CD4+ T-lymphocytes in the reticuloendothelial system and by inhibiting the transcription of cytokines.\u985e\u56fa\u9187\u6291\u5236 \uff34cell \u6a5f\u5236\uff1a\u6d3b\u5316\u9223\u96e2\u5b50\u901a\u9053\u4f9d\u8cf4\u578b\u6838\u9178\u5167\u5207\u8122\u4f86\u7834\u58de\u80f8\u817a\u7d30\u80de\u7684 DNA\uff0c\u9020\u6210 T cell \u6b7b\u4ea1\n"}, {"id": "5556", "aimg": "0", "awall": "\n\u91dd\u5c0d\u514d\u75ab\u6cbb\u7642\u7684\u55ae\u682a\u6297\u9ad4\uff1aRituximab_anti-CD20\uff1anon-Hodgkin's lymphomaAlemtuzumab_anti-CD52\uff1aCMLMuromonab_anti-CD3\uff1a\u814e\u79fb\u690dDaclizumab/Basiliximab_anti-IL-2R\uff1a\u814e\u79fb\u690dInfliximab/Certolizumab/Adalimumab/Golimumab_TNF-alpha\uff1aRATocilizumab_anti-IL-6R\uff1aRACanakinumab_anti-IL-1beta\uff1aMuckle-Wells syndromeDenosumab_anti-RANK-L\uff1a\u9aa8\u8cea\u758f\u9b06Ustekinumab_anti-IL-12/23\uff1a\u4e7e\u766cNatalizumab_anti-alpha4 integrin\uff1aMSOmalizumab_anti-IgE\uff1a\u904e\u654fBelimumab_anti-BLyS\uff1aSLEIpilimumab_anti-CTLA-4\uff1a\u8f49\u79fb\u6027\u9ed1\u8272\u7d20\u7624Raxibacumab_anti-\u70ad\u75bd\u687f\u83ccPA\uff1a\u70ad\u75bd\u687f\u83cc\u611f\u67d3(A)\u00a0Multiple sclerosis \u4ee5 Natalizumab (Anti-VLA-4)\u6cbb\u7642(B)\u00a0Metastatic melanoma \u4ee5 Ipilimumab (Anti-CTLA-4)\u6cbb\u7642(C)\u00a0Chronic myeloid leukemia \u4ee5 Alemtuzumab (Anti-CD52)\u6cbb\u7642\u00a0(D) Chronic asthma \u4ee5 Omalizumab (Anti-IgE)\u6cbb\u7642\n"}, {"id": "5557", "aimg": "0", "awall": "\n\u2460 \u5341\u4e8c\u6307\u8178\u9264\u87f2\u53ef\u7d93\u53e3\u3001\u76ae\u611f\u67d3\uff1b\u7f8e\u6d32\u9264\u87f2\u53ea\u80fd\u7d93\u76ae\u611f\u67d3\u2462 \u7b2c\u4e00\u500b\u75c7\u72c0\u70ba\u8457\u5730\u7662\u2461\u88dc\u5145:\u5341\u4e8c\u6307\u8178\u9264\u87f2\u2192\u8ca7\u8840\u6700\u56b4\u91cd(\u7f3a\u9435\u6027)\u5ee3\u982d\u88c2\u7bc0\u7d5b\u87f2\u2192\u8ca7\u8840(\u7f3aVit. B12)\u554f\u500b\uff0c\u5982\u679c\u4ee5\u98df\u5165\u5c0e\u81f4\u611f\u67d3\u5341\u4e8c\u6307\u8178\u9264\u87f2\u7684\u89d2\u5ea6\u4f86\u60f3\uff0c\u7b2c\u4e00\u500b\u75c7\u72c0\u61c9\u8a72\u662f\u5641\u5fc3\u5614\u5410\uff08\u56e0\u5c0d\u5176\u904e\u654f\u6027\u86cb\u767d\u8cea\u904e\u654f\uff09\uff1f\n"}, {"id": "5558", "aimg": "2758", "awall": "\n(B) \u6b63\u78ba\u3002\u72ac\u9264\u87f2\u7684\u5e7c\u87f2\u7121\u6cd5\u5728\u4eba\u9ad4\u5167\u6210\u719f\uff0c\u5176\u947d\u5165\u76ae\u819a\u5f8c\uff0c\u5c31\u5f85\u5728\u76ae\u4e0b\u79fb\u884c\u9020\u6210\u76ae\u819a\u5e7c\u87f2\u79fb\u884c\u75c7\u3002(A) \u72ac\u5fc3\u7d72\u87f2\u5c6c\u65bc\u8840\u7d72\u87f2\uff0c\u5176\u5e7c\u87f2\u7531\u868a\u5b50\u50b3\u64ad\uff0c\u72d7\u88ab\u868a\u5b50\u53ee\u54ac\u5f8c\uff0c\u5e7c\u87f2\u7531\u8840\u6db2\u81f3\u5fc3\u3001\u80ba\u767c\u80b2\u6210\u719f\uff0c\u9020\u6210\u72d7\u7684\u5fc3\u80ba\u529f\u80fd\u56b4\u91cd\u53d7\u640d\u3002\u4eba\u662f\u5076\u767c\u5bbf\u4e3b\uff0cX \u5149\u53ef\u898b\u80ba\u7d50\u7bc0\u3002\u00a0(C) \u72ac\u86d4\u87f2:\u4eba\u975e\u6b63\u5e38\u5bbf\u4e3b\uff0c\u5e7c\u7ae5\u98df\u5165\u542b\u87f2\u5375\u7684\u8c93\u72d7\u7cde\u4fbf\uff0c\u6703\u9020\u6210\u5167\u81df\u5e7c\u87f2\u79fb\u884c\u75c7\uff0c \u4fb5\u72af\u809d\u9020\u6210\u809d\u816b\u5927\u3001\u4fb5\u72af\u80ba\u5f15\u8d77\u54b3\u55fd\u3001\u4fb5\u72af\u773c\u775b\u9020\u6210\u8996\u7db2\u819c\u525d\u96e2\u3001\u4fb5\u72af\u8166\u90e8\u7b49\u3002\u00a0(D) \u809d\u6bdb\u7dda\u87f2:\u4e3b\u8981\u5bc4\u751f\u5728\u9f20\uff0c\u4eba\u98df\u7528\u542b\u6709\u87f2\u5375\u7684\u751f\u8c6c\u8089\u800c\u611f\u67d3\uff0c\u87f2\u5375\u805a\u7a4d\u5728\u809d\u81df\uff0c\u9020\u6210\u809d\u767c\u708e\u3001\u816b\u5927\u3002\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\n"}, {"id": "5559", "aimg": "0", "awall": "\n(A) \u65e5\u672c\u8840\u5438\u87f2\u7684\u6210\u87f2\u5bc4\u751f\u5728SMV\uff0c\u901a\u5e38\u4f86\u8aaa\u87f2\u5375\u5f71\u97ff\u7684\u662f\u809d\u813e\u816b\u5927\uff0c\u4f46\u5982\u679c\u87f2\u5375\u96a8\u8457\u8840\u6d41\u5230\u8166\u90e8\uff0c\u53ef\u80fd\u6703\u5f15\u8d77\u7672\u7647\u3001\u8166\u708e(B) \u98df\u5165\u87f2\u5375\u6216Autoinfection\u6642\u6703\u9020\u6210Cysticercosis\uff0c\u5bc4\u751f\u5728CNS\u5247\u547d\u540d\u70baNeurocysticercosis(C) \u98df\u5165\u87f2\u5375\uff0c\u5e7c\u87f2\u5f62\u6210Hydatid cyst* \u53ea\u8981\u87f2\u5375\u53ef\u80fd\u51fa\u73fe\u5728\u8840\u6db2\uff0c\u5c31\u6703\u6709\u5168\u8eab\u554f\u984c(By \u74f4\uff09\u9019\u984c\u662f\u9677\u9631\u984c\uff01\u68d8\u53e3\u7dda\u87f2\u6703\u9020\u6210\u55dc\u4f0a\u7d05\u6027\u8166\u819c\u708e\uff0c\u4f46\u68d8\u53e3\u5438\u87f2\u53ea\u6703\u9020\u6210\u8178\u80c3\u9053\u75c7\u72c0\u3002\u4eba\u985e\u975e\u68d8\u984e\u53e3\u7dda\u87f2\u7684\u6b63\u5e38\u5bbf\u4e3b\uff0c\u6545\u5176\u5e7c\u87f2\u7121\u6cd5\u5728\u4eba\u9ad4\u5167\u767c\u80b2\u6210\u87f2\uff0c\u53cd\u800c\u6703\u5230\u8655\u4e82\u722cCLM\uff1a\u722c\u884c\u75b9VLM\uff1a\u8166\u810a\u9ad3\u708eOLM\uff1a\u773c\u5468\u6d6e\u816b\u3001\u773c\u7403\u611f\u67d3\n"}, {"id": "5560", "aimg": "0", "awall": "\n\u7d5b\u87f2\u4e2d\uff0c\u53ea\u6709\u5047\u8449\u76ee\u7d5b\u87f2\u7684\u87f2\u5375\u6709\u5375\u84cb (\u5ee3\u7bc0\u3001\u66fc\u68ee)\u5047\u8449\u76ee_2\u5438\u6e9d2\u4e2d\u9593\u5bbf\u4e3b_\u6709\u5375\u84cb\u5713\u8449\u76ee_4\u5438\u76e41\u4e2d\u9593\u5bbf\u4e3b_\u7121\u5375\u84cb\n"}, {"id": "5561", "aimg": "2765", "awall": "\n\u5730\u7406\u4f4d\u7f6e\u4f9b\u53c3\u8003\uff1a\u5ca1\u6bd4\u4e9e\u9310\u87f2\u7684\u5206\u5e03\u7bc4\u570d\u8f03\u5927(\u6db5\u84cb\u85a9\u8d6b\u723e\u5730\u5340\u3001\u897f\u975e\u3001\u4e2d\u975e\u3001\u90e8\u5206\u6771\u975e)\uff1b\u7f85\u5f97\u897f\u4e9e\u9310\u87f2\u76f8\u8f03\u4e0b\u53ea\u51fa\u73fe\u5728\u80af\u4e9e\u3001\u5766\u5c1a\u5c3c\u4e9e\u3001\u83ab\u4e09\u6bd4\u514b\u3001\u99ac\u62c9\u5a01\u7b49\u6771\u975e\u570b\u5bb6tip:\u5176\u5be6\u53ea\u8981\u77e5\u9053\u76ee\u524d\u5169\u7a2e\u975e\u6d32\u9310\u87f2\u7684\u5206\u5e03\u5340\u57df\u6c92\u6709\u91cd\u758a\u5c31\u597d\u5730\u7406\u5c0f\u5e38\u8b58\uff1a\u6b77\u53f2\u4e0a\u7684 Rhodesia \u5728\u9019\u88e1\n"}, {"id": "5562", "aimg": "1526", "awall": "\nMegaesophagus\uff0d\u67af\u897f\u6c0f\u9310\u87f2\uff08Trypanosoma cruzi\uff09\u00a0\u7ffb\u8b6fD\uff1aEspundia = \u5357\u7f8e\u5229\u4ec0\u66fc\u75c5\n"}, {"id": "5563", "aimg": "0", "awall": "\n\u611f\u67d3\u5f8c\u985e\u4f3c\u7627\u75be\uff0c\u6703\u767c\u71d2\u6eb6\u8840\uff0c\u9020\u6210\u8840\u5c0f\u677f\u4f4e\u4e0b\u3002\u5927\u90e8\u5206\u60a3\u8005\u5448\u73fe\u7121\u75c7\u72c0\u611f\u67d3\u4e4b\u4f4e\u5ea6\u5bc4\u751f\u87f2\u8840\u75c7\u91cd\u75c7\u5e38\u898b\u65bc\u7121\u813e\u81df\u8005\u3001\u8001\u5e74\u4eba\u53ca\u514d\u75ab\u7cfb\u7d71\u5f31\u8005\uff0c\u53ef\u5c0e\u81f4\u591a\u91cd\u5668\u5b98\u8870\u7aed\u53ca\u6b7b\u4ea1\u8a3a\u65b7\u4ee5\u5468\u570d\u8840\u6db2\u62b9\u7247\u70ba\u4e3b\uff08\u5bc4\u751f\u65bc\u7d05\u8840\u7403\u5167\uff09\uff0c\u5728\u7d05\u8840\u7403\u4e2d\u6709\u6212\u6307\u5f62\u72c0\u539f\u87f2\uff0c\u53ef\u4ee5\u884c\u7121\u6027\u751f\u6b96\u5206\u88c2\uff0c\u770b\u8d77\u4f86\u50cf\u96d9\u6838\u72c0\uff0c\u88c2\u6210\u56db\u500b\u88c2\u6b96\u5b50\u6642\uff0c\u53ef\u4ee5\u770b\u5230\u99ac\u723e\u4ed6\u5341\u5b57\u52f3\u7ae0 Maltese Cross\u3002\n"}, {"id": "5564", "aimg": "2766", "awall": "\n\u865b\u7121\u5047\u8a2dH0\u932f\u8aa4\uff08\u5169\u8005\u6709\u5dee\u7570\uff09\u865b\u7121\u5047\u8a2dH0\u6b63\u78ba\uff08\u5169\u8005\u7121\u5dee\u7570\uff09\u63a8\u7ffb\u5047\u8aaaH01-B(= power\u6aa2\u5b9a\u7387)a (type I error)\u63a5\u53d7\u5047\u8aaa H0B(type II error)1-a(\u7d50\u8ad6\u6b63\u78ba)\n"}, {"id": "5565", "aimg": "0", "awall": "\n\u5728\u76f8\u540c\u7684\u986f\u8457\u6c34\u6e96(\u03b1)\u4e0b\uff0c\u96d9\u5c3e\u6aa2\u5b9a\u55ae\u5074\u63a8\u7ffb\u5047\u8aaa\u7684\u7bc4\u570d\u662f \u03b1/2\uff0c\u55ae\u5c3e\u6aa2\u5b9a\u5247\u662f \u03b1\uff0c \u03b1>\u03b1/2\uff0c\u6545\u55ae\u5c3e\u6aa2\u5b9a\u8f03\u5bb9\u6613\u63a8\u7ffb\u865b\u7121\u5047\u8a2d\u3002\u96d9\u5c3e\u6aa2\u5b9a\u82e5\u80fd\u901a\u904e\uff0c\u55ae\u5c3e\u6aa2\u5b9a\u5fc5\u4e5f\u53ef\u901a\u904e\uff0c\u56e0\u70ba\u96d9\u5c3e\u6aa2\u5b9a\u7684 P-value \u70ba\u55ae\u5c3e\u6aa2\u5b9a\u7684\u5169\u500d\uff0c\u6545\u4e00\u822c\u79d1 \u5b78\u7814\u7a76\u591a\u63a1\u7528\u8f03\u4fdd\u5b88\u7684\u96d9\u5c3e\u6aa2\u5b9a\u00a0D.\u00a0But what if you are conducting a\u00a0t-test, which has a two-tailed distribution? Now you will have to decide if a one-tailed or two-tailed test is most appropriate for your study. A two-tailed test is appropriate if you want to determine if there is any difference between the groups you are comparing. For instance, if you want to see if Group A scored higher or lower than Group B, then you would want to use a two-tailed test. This is because a two-tailed test uses both the positive and negative tails of the distribution. In other words, it tests for the possibility of positive or negative differences.A one-tailed test is appropriate if you only want to determine if there is a difference between groups in a specific direction. So, if you are only interested in determining if Group A scored higher than Group B, and you are completely uninterested in possibility of Group A scoring lower than Group B, then you may want to use a one-tailed test. The main advantage of using a one-tailed test is that it has more statistical power than a two-tailed test at the same significance (alpha) level. In other words, your results are more likely to be significant for a one-tailed test if there truly is a difference between the groups in the direction that you have predicted. This is because only one tail of the distribution is used for the test.So, which kind of test should you use? When in doubt, it is almost always more appropriate to use a two-tailed test. A one-tailed test is only justified if you have a specific prediction about the direction of the difference (e.g., Group A scoring higher than Group B), andyou are completely uninterested in the possibility that the opposite outcome could be true (e.g., Group A scoring lower than Group B).\n"}, {"id": "5566", "aimg": "0", "awall": "\n\u76f8\u95dc\u4fc2\u6578\uff52\u4ecb\u65bc1\u8207-1\u4e4b\u9593\uff0c\u5176\u6b63\u8ca0\u8207\uff42\u76f8\u540c\uff1b\u5169\u8005\u70ba\u6b63\u4ee3\u8868\u8cc7\u6599\u5448\u6b63\u76f8\u95dc\uff0c\u70ba\u8ca0\u4ee3\u8868\u5448\u8ca0\u76f8\u95dc\u3002\u82e5\u5c07X\u8207Y\u4e92\u63db\uff0c\u5247\uff42\u5448\u5012\u6578\uff0c\u800c\uff52\u4e0d\u8b8a\u5594\n"}, {"id": "5567", "aimg": "0", "awall": "\n\u7576\u56db\u7d44\u6578\u5b57\u4e0d\u4ee5 ANOVA \u540c\u6642\u6bd4\u8f03\u800c\u4f7f\u7528 t-test \u5169\u5169\u6aa2\u5b9a\u6642\uff0c\u6703\u4f7f \u03b1 \u8b8a\u5927\uff0c\u6b64\u6642 Bonferroni \u6cd5\u4fee\u6b63\u53ef\u4ee5\u4f7f Type I error \u8b8a\u5c0f\u516c\u5f0f\u5728\u6b64:\u03b10'=\u03b10/k\uff0c k=\u6aa2\u5b9a\u7684\u6b21\u6578\u3002\u672c\u984c 4 \u7d44\u5169\u5169\u6bd4\u8f03\uff0c\u6aa2\u5b9a\u6b21\u6578\u70ba C4 \u53d6 2\uff0ck=6 \u82e5\u4e0d\u505a\u6821\u6b63\uff0c\u53ef\u80fd\u6703\u4f7f \u03b1 \u5024\u6700\u5927\u9054\u5230 1-(1-\u03b1)4=0.1855\uff0c\u9060\u5927\u65bc\u6211\u5011\u53ef\u4ee5\u5bb9\u5fcd\u7684 0.05\uff0c\u6240\u4ee5\u518d\u591a\u7d44\u6a23\u672c\u505a\u6aa2\u5b9a\u6642\uff0c\u82e5\u6c92\u6709\u7279\u6b8a\u60c5\u6cc1\uff0c\u4f7f\u7528 ANOVA \u70ba\u8f03\u597d\u7684\u9078\u64c7\u3002\n"}, {"id": "5568", "aimg": "118", "awall": "\n\n"}, {"id": "5569", "aimg": "2772", "awall": "\n\n"}, {"id": "5570", "aimg": "0", "awall": "\n\u901f\u8a18\u6cd5\uff1a\u540d\u5b57\u6709 \u7159\u3001\u9727\u3001\u7070\u3001\u5875\u3001\u6c23\u81a0/\u6c23\u6eb6\u81a0\u3001\u5fae\u7c92\u00a0\u7684\u7686\u5c6c\u65bc\u7c92\u72c0\u6c59\u67d3\u7269(\u4e00) \u6c23\u72c0\u6c59\u67d3\u7269\uff1a\u786b\u6c27\u5316\u7269\uff08SO2 \u53ca SO3 \u5408\u7a31\u70ba SOx\uff09\u3001\u4e00\u6c27\u5316\u78b3\uff08CO\uff09\u3001\u6c2e\u6c27\u5316\u7269 \uff08NO \u53ca NO2 \u5408\u7a31\u70ba NOx\uff09\u3001\u4e8c\u786b\u5316\u78b3\uff08CS2\uff09\u3001\u9e75\u5316\u70f4\u985e\uff08CmHnXx\uff09\u3002\u5168\u9e75\u5316\u70f7\u985e \uff08CFCs\uff09\u3001\u63ee\u767c\u6027\u6709\u6a5f\u7269\uff08VOCs\uff09\u3002\u00a0(\u4e8c) \u7c92\u72c0\u6c59\u67d3\u7269\uff1a\u7e3d\u61f8\u6d6e\u5fae\u7c92\uff08\u61f8\u6d6e\u65bc\u7a7a\u6c23\u4e2d\u4e4b\u5fae\u7c92\uff09\u3001\u61f8\u6d6e\u5fae\u7c92\uff08\u7c92\u5f91\u5728\u5341\u5fae\u7c73\u4ee5 \u4e0b\u4e4b\u7c92\u5b50\uff09\u3001\u843d\u5875\uff08\u7c92\u5f91\u8d85\u904e\u5341\u5fae\u7c73\uff0c\u80fd\u56e0\u91cd\u529b\u9010\u6f38\u843d\u4e0b\u800c\u5f15\u8d77\u516c\u773e\u53ad\u60e1\u4e4b\u7269 \u8cea\uff09\u3001\u91d1\u5c6c\u71fb\u7159\u53ca\u5176\u5316\u5408\u7269\uff08\u542b\u91d1\u5c6c\u6216\u5176\u5316\u5408\u7269\u4e4b\u5fae\u7c92\uff09\u3001\u9ed1\u7159\uff08\u4ee5\u78b3\u7c92\u70ba\u4e3b\u8981 \u6210\u5206\u4e4b\u6697\u7070\u8272\u81f3\u9ed1\u8272\u4e4b\u7159\uff09\u3001\u9178\u9727\uff08\u542b\u786b\u9178\u3001\u785d\u9178\u3001\u78f7\u9178\u3001\u9e7d\u9178\u7b49\u5fae\u6ef4\u4e4b\u7159\u9727\uff09\u3001 \u6cb9\u7159\uff08\u542b\u78b3\u6c2b\u5316\u5408\u7269\u4e4b\u7159\u9727\uff09\u3002\u00a0(\u4e09) \u884d\u751f\u6027\u6c59\u67d3\u7269\uff1a\u5149\u5316\u5b78\u9727\uff08\u7d93\u5149\u5316\u5b78\u53cd\u61c9\u6240\u7522\u751f\u4e4b\u5fae\u7c92\u72c0\u7269\u8cea\u800c\u61f8\u6d6e\u65bc\u7a7a\u6c23 \u4e2d\u80fd\u9020\u6210\u8996\u7a0b\u969c\u7919\u8005\uff09\u3001\u5149\u5316\u5b78\u6027\u9ad8\u6c27\u5316\u7269\uff08\u7d93\u5149\u5316\u5b78\u53cd\u61c9\u6240\u7522\u751f\u4e4b\u5f37\u6c27\u5316\u6027 \u7269\u8cea\uff0c\u5982\u81ed\u6c27\u3001\u904e\u6c27\u785d\u9178\u4e59\u91af\u916f\uff08PAN\uff09\u7b49\u80fd\u5c07\u4e2d\u6027\u7898\u5316\u9240\u6eb6\u6db2\u6e38\u96e2\u51fa\u7898\u8005\u70ba \u9650\uff0c\u4f46\u4e0d\u5305\u62ec\u4e8c\u6c27\u5316\u6c2e\uff09\u3002\u00a0(\u56db) \u6bd2\u6027\u6c59\u67d3\u7269\uff1a\u6c1f\u5316\u7269\u3001\u6c2f\u6c23\uff08Cl2\uff09\u3001\u6c28\u6c23\uff08NH3\uff09\u3001\u786b\u5316\u6c2b\uff08H2S\uff09\u3001\u7532\u919b\uff08HCHO\uff09\u3001 \u542b\u91cd\u91d1\u5c6c\u4e4b\u6c23\u9ad4\u3001\u786b\u9178\u3001\u785d\u9178\u3001\u78f7\u9178\u3001\u9e7d\u9178\u6c23\u3001\u6c2f\u4e59\u70ef\u55ae\u9ad4\uff08VCM\uff09\u3001\u591a\u6c2f\u806f\u82ef \uff08PCBs\uff09\u3001\u6c30\u5316\u6c2b\uff08HCN\uff09\u3001\u6234\u5967\u8f9b\u985e\uff08Dioxins \u53ca Furans\uff09\u3001\u81f4\u764c\u6027\u591a\u74b0\u82b3\u9999\u70f4\u3001 \u81f4\u764c\u63ee\u767c\u6027\u6709\u6a5f\u7269\u3001\u77f3\u7dbf\u53ca\u542b\u77f3\u7dbf\u4e4b\u7269\u8cea\u3002\u00a0(\u4e94) \u60e1\u81ed\u6c59\u67d3\u7269\uff1a\u786b\u5316\u7532\u57fa [(CH3)2S] \u3001\u786b\u9187\u985e\uff08RSH\uff09\u3001\u7532\u57fa\u80fa\u985e\n"}, {"id": "5571", "aimg": "0", "awall": "\n\u98a8\u96aa\u8a55\u4f30\u5177\u6709\u4e0b\u5217\u56db\u500b\u6b65\u9a5f:(\u4e00) \u5371\u5bb3\u8fa8\u8b58(Hazard identification):\u98a8\u96aa\u8a55\u4f30\u7684\u7b2c\u4e00\u500b\u6b65\u9a5f:\u300e\u6c7a\u5b9a\u67d0\u4e00\u7269\u8cea\u662f\u5426\u6703\u589e\u52a0\u67d0\u7a2e\u5065\u5eb7\u72c0\u614b(\u5982\u764c\u75c7\u3001\u5148\u5929\u7f3a\u9677\u7b49)\u4e4b\u767c\u751f\u7387\u7684\u904e\u7a0b\u300f(\u4e8c) \u5291\u91cf\u53cd\u61c9\u8a55\u4f30(Dose-response assessment):\u300e\u4e00\u7a2e\u7269\u8cea\u7684\u5291\u91cf\uff0c\u8207\u66b4\u9732\u4eba \u7fa4\u4e2d\u67d0\u7a2e\u4e0d\u826f\u5065\u5eb7\u6548\u61c9\u767c\u751f\u7387\u4e4b\u9593\u95dc\u4fc2\u7684\u63cf\u8ff0\uff0c\u4e26\u4e14\u4ee5\u4eba\u985e\u66b4\u9732\u5230\u6b64\u7269\u8cea\u7684\u51fd\u6578\uff0c\u4f86\u4f30\u8a08\u6b64\u6548\u61c9\u7684\u767c\u751f\u7387\u4e4b\u904e\u7a0b\u300f(\u4e09) \u66b4\u9732\u8a55\u4f30(Exposure assessment):\u300e\u6e2c\u91cf\u6216\u4f30\u8a08\u4eba\u9ad4\u66b4\u9732\u5230\u76ee\u524d\u5b58\u5728\u65bc\u74b0\u5883\u4e2d\u7269\u8cea\u7684\u7a0b\u5ea6\u3001\u983b\u7387\u548c\u6301\u7e8c\u671f\u9593\uff0c\u6216\u4f30\u8a08\u65b0\u5316\u5b78\u7269\u9032\u5165\u74b0\u5883\u4e2d\u6240\u53ef\u80fd\u5f15\u8d77\u7684\u5047\u8a2d\u6027\u66b4\u9732\u4e4b\u904e\u7a0b\u300f(\u56db) \u98a8\u96aa\u7279\u6027\u63cf\u8ff0(Risk characterization):\u300e\u5728\u66b4\u9732\u8a55\u4f30\u4e2d\u6240\u63cf\u8ff0\u7684\u5404\u7a2e\u4eba\u9ad4\u66b4\u9732\u72c0\u6cc1\u4e4b\u4e0b\uff0c\u4f30\u8a08\u5065\u5eb7\u6548\u61c9\u7684\u767c\u751f\u7387\u4e4b\u904e\u7a0b\u3002\u85c9\u8457\u7d50\u5408\u66b4\u9732\u8a55\u4f30\u53ca\u5291\u91cf\u53cd\u61c9\u8a55\u4f30\u4f86\u9032\u884c\uff0c\u5148\u524d\u6b65\u9a5f\u4e4b\u4e0d\u78ba\u5b9a\u6027\u7684\u7d9c\u5408\u6548\u61c9\uff0c\u5728\u6b64\u6b65\u9a5f\u4e2d\u9700\u52a0\u4ee5\u8aaa\u660e\u300f\u00a0\u98a8\u96aa\u7279\u6027\u63cf\u8ff0\u53c8\u53ef\u5206\u6210\u81f4\u764c\u98a8\u96aa\u5ea6\u53ca\u975e\u81f4\u764c\u98a8\u96aa\u5ea6\uff0c\u5176\u4e2d\u975e\u81f4\u764c\u98a8\u96aa\u5ea6\u5305\u542b\u4ee5\u4e0b \u5169\u500b\u89c0\u5ff5:(\u4e00) \u5371\u5bb3\u5546\u6578:\u6bd4\u8f03\u5e73\u5747\u6bcf\u65e5\u66b4\u9732\u5291\u91cf(Average Daily Dose, ADD)\u8207\u5371\u5bb3\u6027\u5316\u5b78\u7269\u8cea\u7684\u53c3\u8003\u5291\u91cf(RfD)\uff0c\u91dd\u5c0d\u7279\u5b9a\u4e4b\u66b4\u9732\u9014\u5f91\uff0c\u6c42\u5f97\u5169\u8005\u7684\u6bd4\u5024\u800c\u5f97\u5371\u5bb3\u5546\u6578(hazard quotient, HQ)\uff0c\u5373 HQ=ADD/RfD(\u4e8c) \u5371\u5bb3\u6307\u6a19: \u5c07\u5404\u7a2e\u5371\u5bb3\u6027\u5316\u5b78\u7269\u8cea\u4e4b\u5404\u7a2e\u66b4\u9732\u9014\u5f91\u4e4b\u5371\u5bb3\u5546\u6578\u52a0\u7e3d\u5f8c\uff0c\u7372\u5f97\u5371\u5bb3\u6307\u6a19(hazardindex,HI)\uff0c\u5373HI=\u03a3HQ\u3002 \u82e5\u679c\u5371\u5bb3\u6307\u6a19\u5c0f\u65bc1\uff0c\u9810\u671f\u5c07\u4e0d\u6703 \u9020\u6210\u986f\u8457\u640d\u5bb3\uff0c\u82e5\u5371\u5bb3\u6307\u6a19\u5927\u65bc 1\uff0c\u5247\u66b4\u9732\u5291\u91cf\u8d85\u904e\u95be\u5024\uff0c\u53ef\u80fd\u7522\u751f\u6bd2\u6027\u3002\n"}, {"id": "5572", "aimg": "0", "awall": "\n\u63db\u6c23\u7684\u904e\u7a0b\u4e0d\u6703\u964d\u4f4e\u6c23\u58d3(\u591a\u5c11\u6c23\u51fa = \u591a\u5c11\u6c23\u9032)\n"}, {"id": "5573", "aimg": "0", "awall": "\n(A) \u9748\u4e39(lindane)\uff1a\u03b3-\u516d\u6c2f\u74b0\u5df1\u70f7(\u03b3-HCH)\uff0c\u8fb2\u85e5\u7684\u4e00\u7a2e\uff0c\u6709\u81f4\u816b\u7624\u6027\uff0c\u6c11\u570b 74 \u5e74\u5f8c \u7981\u7528\u3002\u6c92\u627e\u5230\u76f8\u95dc\u65b0\u805e\uff0c\u6240\u4ee5\u61c9\u8a72\u6c92\u5728\u53f0\u7063\u5f15\u767c\u4ec0\u9ebc\u91cd\u5927\u4e8b\u60c5\u904e\u3002\u00a0(B)\u591a\u6c2f\u806f\u82ef(PCB)\uff1a\u53ef\u9020\u6210\u6cb9\u75c7\uff08Yush\u014d disease\uff09\uff0c\u65e5\u672c(1968)\u53ca\u53f0\u7063(1979)\u90fd\u66fe\u767c\u751f\u98df\u7528 PCB \u6c59\u67d3\u5f8c\u7684\u7c73\u7ce0\u6cb9\u800c\u4e2d\u6bd2\u7684\u4e8b\u4ef6\u3002(C) \u7532\u82ef(toluene)\uff1a\u82ef\u985e\u6709\u7206\u70b8\u6027\uff0c\u6709\u9aa8\u9ad3\u6291\u5236\u6027\uff0c\u6703\u5f15\u767c\u767d\u8840\u75c5\u3002\uff08From \u5c0f\u7da0\u672c\uff09\u00a0(D)\u6709\u6a5f\u6c5e(organic mercury)\uff1a\u6709\u6a5f\u6c5e\u6703\u5f71\u97ff\u8996\u89ba\u3001\u807d\u89ba\u3001\u611f\u89ba\u795e\u7d93\uff1b\u6709\u5c0f\u8166\u75c7\u72c0\uff1b \u5f71\u97ff\u80ce\u5152\u4e2d\u6a1e\u795e\u7d93\u3002\uff08From \u5c0f\u7da0\u672c\uff09 \n"}, {"id": "5574", "aimg": "0", "awall": "\n\u76ee\u524d\u9084\u6c92\u6709\u8a73\u89e3\u3002\n"}, {"id": "5575", "aimg": "0", "awall": "\n\u76ee\u524d\u9084\u6c92\u6709\u8a73\u89e3\u3002\n"}, {"id": "5576", "aimg": "0", "awall": "\n\u5f62\u5f0f\u8a55\u50f9 : \u8a08\u756b\u7684\u9069\u5207\u6027 (\u8a08\u756b\u7684\u9700\u6c42\u6027\u8a55\u4f30) \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 / \u8a72\u4e0d\u8a72\u505a ?\u904e\u7a0b\u8a55\u50f9 : \u627e\u51fa\u8a08\u756b\u904e\u7a0b\u7684\u7f3a\u9677\uff0c\u4ee5\u53ca\u57f7\u884c\u7684\u5b8c\u6210\u5ea6 \u00a0 \u00a0/ \u57f7\u884c\u6709\u6c92\u6709\u78ba\u5be6?\u885d\u64ca\u8a55\u50f9 : \u77ed\u671f\u6539\u8b8a (\u8a8d\u77e5\u884c\u70ba\u7684\u6539\u8b8a) \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0/ \u505a\u5b8c\u5f8c\u6c11\u773e\u601d\u60f3\u6709\u6c92\u6709\u6539\u8b8a?\u7d50\u679c\u8a55\u50f9 : \u9577\u671f\u6539\u8b8a (\u7f79\u60a3\u7387\u3001\u6b7b\u4ea1\u7387\u53ca\u5065\u5eb7\u72c0\u6cc1) \u00a0 \u00a0 \u00a0 \u00a0/ \u6b7b\u4ea1\u7387\u6709\u6c92\u6709\u4e0b\u964d ?\n"}, {"id": "5577", "aimg": "0", "awall": "\n\u5782\u76f4\u6574\u5408\u65e8\u5728\u64f4\u5927\u7522\u503c\u6216\u7d93\u71df\u6210\u6548\uff0c\u56e0\u6b64\u5c6c\u65bc\u6210\u9577\u7b56\u7565\u9019\u984c\u8003\u7ba1\u7406\u5b78\uff0c\u8b80\u570b\u8003\u4e0d\u592a\u53ef\u80fd\u5538\u5230\uff0c\u4f46\u5176\u5be6\u770b\u5b57\u9762\u5c31\u80fd\u63a8\u8ad6\u51fa\u7b54\u6848\u4e86\uff01 (A)(D)\u4e00\u770b\u5c31\u77e5\u9053\u6b63\u78ba\uff0c\u800c(B)(C)\u4e4b\u9593\u4e00\u6bd4\u4e5f\u53ef\u63a8\u8ad6\u7a69\u5b9a\u7b56\u7565\u8ddf(C)\u7684\u6558\u8ff0\u8f03\u63a5\u8fd1\u3002 \u516c\u885b\u5e38\u5e38\u8003\u4e00\u4e9b\u6c92\u770b\u904e\u7684\u6771\u897f\uff0c\u4f46\u53ea\u8981\u975c\u4e0b\u5fc3\u770b\u5b8c\uff0c\u90fd\u53ef\u4ee5\u9078\u51fa\u7b54\u6848\uff5e\n"}, {"id": "5578", "aimg": "0", "awall": "\n(\u4e00) \u7b2c\u4e00\u671f \u4e3b\u8981\u76ee\u7684\u5728\u65bc\u85e5\u7269\u7684\u5b89\u5168\u6027\uff0c\u901a\u5e38\u7a31\u70ba\u300c\u81e8\u5e8a\u85e5\u7406\u5b78\u7814\u7a76\u300d\uff0c\u4fc2\u4ee5\u4e00\u5c0f\u7fa4\u500b\u4f4d \u6578\u81f3\u5341\u4f4d\u6578\u7684\u5065\u5eb7\u53d7\u8a66\u8005\uff0c\u6709\u6642\u4e5f\u6703\u76f4\u63a5\u4ee5\u75c5\u60a3\u4f86\u7576\u53d7\u8a66\u8005\uff0c\u6e2c\u8a66\u78ba\u8a8d\u4f7f\u7528 \u65bc\u4eba\u9ad4\u4e4b\u5b89\u5168\u5291\u91cf\u7bc4\u570d\u7b49\u5b89\u5168\u6027\u8cc7\u8a0a\u3002\u00a0(\u4e8c) \u7b2c\u4e8c\u671f \u4e3b\u8981\u76ee\u7684\u662f\u85e5\u7269\u7642\u6548\u53ca\u9032\u4e00\u6b65\u7684\u5b89\u5168\u6027\u8a55\u4f30\u3002\u6b64\u7814\u7a76\u9700\u8981\u7d04\u767e\u4f4d\u81f3\u5343\u4f4d\u60a3\u6b64 \u75be\u75c5\u7684\u53d7\u8a66\u8005\u53c3\u8207\u3002\u9019\u4e00\u671f\u5c07\u5efa\u7acb\u300c\u6982\u5ff5\u6027\u9a57\u8b49\u300d\uff0c\u4ea6\u5373\u8b49\u660e\u85e5\u7269\u78ba\u5be6\u53ef\u4ee5\u6709 \u6548\u6cbb\u7642\u6b64\u75be\u75c5\u3002\u00a0(\u4e09) \u7b2c\u4e09\u671f \u4e3b\u8981\u76ee\u7684\u662f\u5728\u85e5\u7269\u88ab\u6279\u51c6\u4e0a\u5e02\u524d\u7684\u6700\u5f8c\u9a57\u8b49\u6027\u7814\u7a76\uff0c\u901a\u5e38\u88ab\u7a31\u70ba\u6a1e\u7d10\u8a66\u9a57\u3002 \u4e3b\u8981\u7814\u7a76\u8a2d\u8a08\u70ba\u5927\u578b\u3001\u96a8\u6a5f\u3001\u5c0d\u7167\u7684\u8a66\u9a57\uff0c\u53c3\u8207\u7684\u53d7\u8a66\u75c5\u60a3\u6578\u91cf\u53ef\u9054\u5343\u4f4d\u81f3\u842c\u4f4d\uff0c\u53ef\u80fd\u65bc\u8de8\u570b\u6216\u591a\u500b\u91ab\u5b78\u4e2d\u5fc3\u57f7\u884c\u3002\u7814\u7a76\u4eba\u54e1\u6703\u5b9a\u671f\u5bc6\u5207\u76e3\u6e2c\u75c5\u60a3\uff0c\u4ee5\u78ba\u8a8d\u8a72\u85e5\u7269\u7684\u85e5\u6548\uff0c\u4e26\u6536\u96c6\u66f4\u591a\u95dc\u65bc\u8a72\u85e5\u7269\u4e4b\u526f\u4f5c\u7528\u3002\u00a0(\u56db) \u7b2c\u56db\u671f \u53c8\u7a31\u70ba\u4e0a\u5e02\u5f8c\u76e3\u6e2c\u671f\uff0c\u4e3b\u8981\u76ee\u7684\u70ba\u65b0\u7684\u85e5\u7269\u3001\u91ab\u7642\u5668\u6750\u6216\u6cbb\u7642\u65b9\u6cd5\u901a\u904e\u8a72\u570b \u885b\u751f\u4e3b\u7ba1\u6a5f\u95dc\u6838\u51c6\u4e0a\u5e02\u5f8c\uff0c\u85e5\u5ee0\u6703\u7e7c\u7e8c\u9032\u884c\u5b89\u5168\u6027\u7814\u7a76\u4e26\u6301\u7e8c\u76e3\u6e2c\u526f\u4f5c\u7528\u7684 \u7522\u751f\u8207\u901a\u5831\uff0c\u4ee5\u66f4\u52a0\u78ba\u5b9a\u5176\u5b89\u5168\u548c\u6709\u6548\u6027\u3002\u00a0\u2605\u7c21\u55ae\u7e3d\u7d50\uff1a\u7b2c\u4e00\u671f\u6578\u5341\u4eba\uff0c\u7b2c\u4e8c\u671f\u6578\u767e\u4eba\uff0c\u7b2c\u4e09\u671f\u6578\u5343\u4eba\uff0c\u7b2c\u56db\u671f\u4e0a\u5e02\u5f8c \n"}, {"id": "5579", "aimg": "0", "awall": "\nLevofloxacin \u662f \u7b2c \u4e09 \u4ee3 \u7684 Fluoroquinolone \u985e \u6297 \u751f \u7d20 ( -floxacin ) \u3002 Fluoroquinolone \u985e\u6297\u751f\u7d20\u4e3b\u8981\u662f\u5c0d\u6297\u9670\u6027\u83cc\uff0c\u800c Levofloxacin \u9084\u591a\u589e\u52a0\u4e86 \u967d\u6027\u83cc\u7684\u6297\u83cc\u529b\u3002Sulfacetamide \u5c6c\u65bc\u78fa\u80fa\u985e\u6297\u751f\u7d20\u3002\u8207\u6211\u5011\u6240\u719f\u6089\u7684 Sulfamethoxazole (SMX)\u662f\u4e0d\u540c\u7684\u6297\u751f\u7d20\uff0c\u4f46\u5169\u8005\u7686\u5c6c\u65bc\u78fa\u80fa\u985e\u6297\u751f\u7d20\uff0c\u6a5f\u5236\u7686\u70ba\u8207 PABA \u7af6\u722d \u4ee5\u6291\u5236 dihydropteroate synthase \u800c\u6e1b\u5c11 dihydrofolic acid \u7684\u5408\u6210\u3002\u4e0d\u540c\u8655\u5728\u65bc Sulfacetamide \u662f\u5916\u7528\u85e5\uff0c\u9069\u7528\u65bc\u76ae\u819a\u8868\u9762\u611f\u67d3;\u800c Sulfamethoxazole (SMX)\u5df2\u4e0d\u518d\u55ae\u7368\u4f7f\u7528\uff0c\u901a\u5e38\u8207 Trimethoprim(TMP)\u4f75\u7528\u4ee5\u6cbb\u7642 AIDS \u60a3\u8005 \u7684 PCP\u3001Nocardiosis\u3001Toxoplasmosis\u3001\u6ccc\u5c3f\u9053\u611f\u67d3(E. coli)\u6216\u611f\u67d3\u6027\u8179\u7009 (Shigella, Salmonella)\u3002Trimethoprim \u6a5f\u5236\u70ba\u6291\u5236 dihydrofolate reductase \u800c\u6e1b\u5c11 tetrahydrofolic acid \u7684\u88fd\u9020\u3002\u7bc4\u570d\u5982\u4e0b\uff0c\u4f46\u91dd\u5c0d\u6ccc\u5c3f\u9053\u611f\u67d3\u53ca\u611f\u67d3\u6027\u8179\u7009\uff0c\u76f8\u5c0d\u65bc-floxacin \u985e \u6709\u8f03\u9ad8\u7684\u6297\u85e5\u6027\uff0c\u6545\u63a8\u6e2c\u9996\u9078\u85e5\u7269\u61c9\u8a72\u9084\u662f-floxacin \u985e\u7684\u70ba\u4e3b\u3002(BC)\u901a\u5e38\u5408\u7528\uff0c\u5408\u7406\u63a8\u65b7\u4e0d\u6703\u662f\u5176\u4e2d\u4e4b\u4e00\u3002TMP+SMX\u901a\u5e38\u7528\u65bc\u80ba\u56ca\u87f2\u3001\u5f13\u6f3f\u87f2\u3001Nocardia\u7b49\u7279\u6b8a\u83cc(D)\u7528\u5728G(+)\u6709\u6297\u85e5\u6027\u7684\u83cc\u6545\u7528\u6392\u9664\u6cd5\u53ef\u9078(A)\n"}, {"id": "5580", "aimg": "2783", "awall": "\n\n"}, {"id": "5581", "aimg": "2785", "awall": "\n\n"}, {"id": "5582", "aimg": "2788", "awall": "\n\u80cc\uff01\n"}, {"id": "5583", "aimg": "0", "awall": "\nA. Albuterol \u70ba \u03b22 agonist\uff0c\u6d3b\u5316 adenyl cyclase\uff0c\u589e\u52a0\u5e73\u6ed1\u808c cAMP \u542b\u91cf\uff0c\u4f7f\u5e73\u6ed1\u808c\u653e\u9b06\u3001\u6c23\u7ba1\u64f4\u5f35\u3002Albuterol \u7528\u5728\u5feb\u901f\u7d13\u7de9\u75c7\u72c0\uff08SABA\uff09\u3002B. Theophylline \u70ba\u8336\u9e7c\u985e\u85e5\u7269\uff08\u5982\u540c\u5496\u5561\u56e0\uff09\uff0c\u85c9\u7531\u6291\u5236 phosphodiesterase \u4f86\u6e1b\u5c11 cAMP \u5206\u89e3\uff0c\u4ee5\u589e\u52a0\u5e73\u6ed1\u808c cAMP \u542b\u91cf\uff0c\u4f7f\u6c23\u7ba1\u653e\u9b06\u3002Theophylline \u8f03\u5e38\u7528\u5728 COPD\u3002C. Salmeterol \u4e5f\u662f \u03b22 agonist\uff0c\u4f46\u7528\u5728 long-term control\uff08LABA\uff09\u3002D. Cromolyn \u53ca nedocromil \u70ba mast cell stabilizers\uff0c\u53ea\u9069\u5408\u7528\u65bc\u9810\u9632\u6c23\u5598\u767c\u4f5c\u3002\n"}, {"id": "5584", "aimg": "0", "awall": "\nA. Buspirone \u70ba 5HT1A receptor partial agonist\uff0c\u7528\u65bc\u6cbb\u7642\u6050\u614c\u75c7\uff0c\u96d6\u4f5c\u7528\u6162\uff0c\u4f46\u7121\u6210\u766e\u6027\uff0c\u526f\u4f5c\u7528\u4e5f\u5c11\u3002B. Sumatriptan \u70ba 5HT1D agonist\uff0c\u7528\u4f86\u6cbb\u7642 migraine\u3002\u9019\u985e\u85e5\u7269\u53ef\u80fd\u9020\u6210\u8840\u7ba1\u7e2e\uff0c\u5982\u51a0\u72c0\u52d5\u8108\u75d9\u6523\uff0c\u6240\u4ee5\u6709\u51a0\u72c0\u52d5\u8108\u75be\u75c5\u3001\u672b\u68a2\u5faa\u74b0\u969c\u7919\u8005\u4e0d\u5b9c\u4f7f\u7528\u3002C. Propranolol \u70ba \u03b2 blocker\uff0c\u53ef\u7528\u4f86\u9810\u9632 migraine\uff08\u5e38\u7528\uff09*\u9810\u9632\u504f\u982d\u75db ACEi\u3001ARB\u3001\u03b2-blocker\u3001Botox\u3001CCB\u3001anti-Depressant\u3001anti-Epileptic D. Dihydroergotamine \u70ba partial 5-HT agonist + \u03b1 agonist + dopamine agonist\uff0c\u53ef\u7528\u4f86\u6cbb\u7642 migraine\u3002\n"}, {"id": "5585", "aimg": "0", "awall": "\n\u4e59\u9187\u9032\u5165\u8eab\u9ad4\u5f8c\u7684\u6bd2\u6027\u4e3b\u8981\u4f86\u81ea\u5176\u4ee3\u8b1d\u7269\u4e59\u919b\u3002\u4e59\u9187\u4ee3\u8b1d\u6210\u4e59\u919b\uff0c\u4ee5\u53ca\u4e59\u919b\u518d\u88ab\u4ee3\u8b1d\u6210\u4e59\u9178\uff0c\u90fd\u662f\u5728\u809d\u81df\u5167\u9032\u884c\u3002\u56e0\u6b64\uff0c\u809d\u7684\u529f\u80fd\u6c7a\u5b9a\u4e86\u4e59\u919b\u5728\u9ad4\u5167\u7684\u6fc3\u5ea6\u8207\u6301\u7e8c\u6642\u9593\u3002\u4ee5\u4e0a\u662f\u500b\u4eba\u898b\u89e3\uff0c\u82e5\u6709\u8aa4\uff0c\u6b61\u8fce\u66f4\u6b63\u3002\n"}, {"id": "5586", "aimg": "0", "awall": "\n\u4e00\u3001\u4f5c\u7528\u65bc\u53d7\u9ad4\u7684\u85e5\u7269\uff08\u4e00\uff09\u6fc0\u52d5\u85e5\u8207\u90e8\u5206\u6fc0\u52d5\u85e51\uff0e\u6fc0\u52d5\u85e5 (agonist) \u8207\u53d7\u9ad4\u6709\u89aa\u548c\u529b\u53c8\u6709\u5167\u5728\u6d3b\u6027\u85e5\u7269\u5b8c\u5168\u6fc0\u52d5\u85e5 (full agonist) : \u03b1= 12\uff0e\u90e8\u5206\u6fc0\u52d5\u85e5\uff08partial agonist,mixed agonist) \uff1a\u8207\u53d7\u9ad4\u6709\u89aa\u548c\u529b\uff0c\u4f46\u5167\u5728\u6d3b\u6027\u8f03\u5f31\uff08\u03b1<1\uff09\u3002\uff08\u4e8c\uff09\u7af6\u722d\u6027\u62ee\u6297\u85e5 (competitive antagonist) \u548c\u975e\u7af6\u722d\u6027\u62ee\u6297\u85e5\uff08non-competitive antagonist\uff09\u62ee\u6297\u85e5\uff08antagonist\uff09\uff1a\u8207\u53d7\u9ad4\u6709\u89aa\u548c\u529b\uff0c\u800c\u7121\u5167\u5728\u6d3b\u6027\u7684\u85e5\u7269\uff08\u03b1= 0\uff09\u30021\uff0e\u7af6\u722d\u6027\u62ee\u6297\u85e5\uff08competitive antagonist\uff09\u8207\u6fc0\u52d5\u85e5\u7af6\u722d\u540c\u4e00\u53d7\u9ad4\u7684\u62ee\u6297\u85e5\u3002Efficacy:\u53ef\u4ee5\u7522\u751f\u7684\u6700\u5927\u85e5\u6548, y=VmaxPotency:\u7279\u5b9a\u85e5\u6548\u4e0b\u6240\u9700\u8981\u7684\u85e5\u7269\u5291\u91cf, y=EC50 (Effective dose\u9700\u8981\u7684\u85e5\u91cf)\uff0cEC\u8d8a\u5c0fpotency\u8d8a\u5927PotencyEfficacy\u5291\u91cf\u4e0a\u5347\u89e3\u6c7a\u4f8b\u5b50competitive antagonist\u4e0b\u964d\u4e0d\u8b8a\u53ef\u4ee5Diazepam+Flumazenil @ GABA Anoncompetitive antagonist\u4e0d\u8b8a\u4e0b\u964d\u4e0d\u884cNE+phenoxybenzamine@ alpha-Rpartial agonist\u7368\u7acb\u4e0b\u964d\u540c\u5730\u65b9as full agonistmorphine+buprenorphine at opioid miu-R*\u8907\u7fd2\u751f\u5316 : \u9175\u7d20Km : \u5230\u90541/2 Vmax\u6240\u9700\u7684\u53d7\u8cea\u6fc3\u5ea6 (\u4ee3\u8868\u89aa\u548c\u529b) <-> EC50 (\u85e5\u7269\u4f7f50\uff05\u7684\u4eba\u7522\u751f\u6548\u679c\u7684\u5291\u91cf)\uff0c\u6982\u5ff5\u5f88\u50cf\u4f46\u4e0d\u540c\u82e5\u4e00\u500b\u53cd\u61c9\u5f0f\u9175\u7d20\u70baE\u3001\u53d7\u8cea\u70baS\u3001\u7522\u7269\u70baP\u3001\u6291\u5236\u7269\u70baI\uff0c\u53ef\u4ee5\u5beb\u6210E+S \u21d4 \u00a0ES -> E+P+ \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 +I \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0I'\u21d5 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u21d5\u00a0EI \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 ESI'KmVmaxInhibitor\u985e\u578bCompetitive\u4e0b\u964d\u4e0d\u8b8aI : \u7d50\u5408\u9175\u7d20\u7af6\u722d\u6291\u5236Noncompetitive\u4e0d\u8b8a\u4e0b\u964dI+I' : \u53c8\u540dMix inhibitionUncompetitive\u4e0a\u5347\u4e0b\u964dI' : \u7d50\u5408ES complex\uff0c\u6539\u8b8a\u9175\u7d20\u6d3b\u6027\u4e2d\u5fc3\u7684\u7d50\u69cb\n"}, {"id": "5587", "aimg": "2805", "awall": "\nA. inhibit Mycolic acid => Inihibt cell wall synthesisB. \u53ef\u4ee5\u806f\u60f3\u4e00\u4e0b\u7d50\u6838\u75c5\u9632\u6cbb\u7684\u300c\u90fd\u6cbb\u8a08\u756b\u300d\u2014\u2014\u7531\u8b77\u7406\u5e2b\u6bcf\u5929\u9001\u85e5\u5230\u60a3\u8005\u5bb6\u4e2d\uff0c\u7576\u5834\u76e3\u7763\u60a3\u8005\u628a\u85e5\u541e\u4e0b\u3002\u6240\u4ee5\u986f\u7136\u7d50\u6838\u75c5\u7684\u85e5\u662f\u53e3\u670d\u7684\u3002C. \u7531\u809d\u81df\u4e4b\u00a0N-acetyltransferase\u00a0\u4ee3\u8b1d\u4e4b\u85e5\u7269\u4e3b\u8981\u6709\u4e09\u500b\uff1aHydralazine\u3001Procainamide\u3001Isoniazid\u6b64\u9175\u7d20\u7684\u6d3b\u6027\u6709\u500b\u9ad4\u5dee\u7570\uff0c\u5982\u679c\u662f\u4ee3\u8b1d\u8f03\u6162\u7684\u4eba\uff0c\u5c31\u8f03\u5bb9\u6613\u7522\u751f drug-induced SLED. \u61c9\u70ba ethambutol\n"}, {"id": "5588", "aimg": "0", "awall": "\n\u4e0d\u5efa\u8b70\u7528\u65bc\u5b55\u5a66\u7684\u6297\u751f\u7d20\u4e3b\u8981\u6709\u56db\u985e:Macrolides(\u81bd\u6c41\u9b31\u7a4d\u6027\u809d\u708e)\u3001Fluoroquinolones(\u8edf\u9aa8\u7578\u5f62)\u3001 Sulfonamides(G6PD\u6eb6\u8840)\u3001 Tetracyclines(\u5f71\u97ff\u9aa8\u9abc&\u80ce\u5152\u7578\u5f62)A) erythromycin estolate \u00a0\u6709\u5b55\u5a66\u809d\u6bd2\u6027B) streptomycin \u80ce\u5152CN8\u53d7\u640dC) \u6b63\u78baD) tetracycline \u9aa8\u9abc\u767c\u80b2\u7570\u5e38 \uff08\u7070\u5b30\u75c7\u5019\u7fa4\u2192chloramphenicol\uff09G6PDdeficiency\u60a3\u8005\u4e0d\u80fd\u4f7f\u7528:\u00a0\u6297\u7627\u75be\u85e5\u7269(Quinine)\u3001\u78fa\u80fa\u985e(Sulfonamides)\u3001\u90e8\u5206\u6297\u751f\u7d20(Dapsone, Chloramphenicol, Nitrofuran)\u3001Aminosalicylic acid\u3001Vitamin K analog\u3002\n"}, {"id": "5589", "aimg": "0", "awall": "\n\u5e38\u898bcyp 450\u8a98\u5c0e\u5291:phenobarbital,phenytoin,rifampinA.B.C. \u90fd\u662f\u6291\u5236cyp 450\n"}, {"id": "5590", "aimg": "0", "awall": "\nA. Abacavir \u70ba anti-HIV \u7576\u4e2d\u7684 NRTI\u3002B. Acyclovir \u70ba nucleoside analogue\uff0c\u6cbb\u7642 HSV\u3001VZV\uff0c\u540d\u85e5\uff0c\u8a18\uff01C. Amantadine \u662f\u4fc3\u9032\u591a\u5df4\u80fa\u91cb\u653e\u85e5\u7269\uff0c\u6a5f\u5236\u4e0d\u660e\uff0c\u6cbb\u7642\u5df4\u91d1\u68ee\u6c0f\u75c7\u3002D. Azidothymidine (AZT) \u5373 zidovudine (ZDV)\uff0c\u70ba anti-HIV \u7684 NRTI\u3002\n"}, {"id": "5591", "aimg": "0", "awall": "\nA. Statins \u85e5\u7269\u70ba HMG-CoA reductase inhibitors\uff0c\u76f4\u63a5\u6e1b\u5c11\u81bd\u56fa\u9187\u5408\u6210\uff0c\u9593\u63a5\u4fc3\u4f7f\u809d\u81df\u56de\u6536 LDL\uff0c\u9054\u5230\u964d\u8840\u8102\u7684\u6548\u679c\u3002\u526f\u4f5c\u7528\u5305\u62ec\u809d\u6307\u6578\u4e0a\u5347\u3001\u808c\u8089\u9178\u75db\uff08\u56b4\u91cd\u8005\u6a6b\u7d0b\u808c\u6eb6\u89e3\uff09\u3001\u6d88\u5316\u9053\u75c7\u72c0\u3001\u76ae\u819a\u75b9\u3002\u6548\u679c\u597d\uff0c\u526f\u4f5c\u7528\u5c11\uff0c\u56e0\u6b64\u5e38\u7528\u3002B. Metformin \u70ba biguanides anti-diabetic agent\uff0c\u85c9\u7531\u6d3b\u5316 AMP kinase \u4f86\u589e\u52a0\u7d44\u7e54\u5c0d\u8461\u8404\u7cd6\u7684\u5438\u6536\u3001\u6e1b\u5c11\u809d\u81df\u7cd6\u8cea\u65b0\u751f\u7b49\u3002\u53e6\u5916\u9084\u53ef\u6e1b\u5c11\u8102\u80aa\u809d\u3001\u6e1b\u80a5\u3001\u964d\u4f4e\u5fc3\u8840\u7ba1\u75be\u75c5\u98a8\u96aa\u3001\u964d\u4f4e\u6b7b\u4ea1\u7387\u7b49\u7b49\uff0c\u597d\u8655\u591a\u591a\uff0c\u56e0\u6b64\u70ba\u7b2c\u4e00\u7dda\u7528\u85e5\u3002\u5f88\u5c11\u5c0e\u81f4\u4f4e\u8840\u7cd6\uff0c\u5176\u526f\u4f5c\u7528\u6709\u8f15\u5fae\u6d88\u5316\u9053\u75c7\u72c0\uff0c\u6700\u56b4\u91cd\u5247\u662f lactic acidosis\uff0c\u4f46\u5f88\u5c11\u767c\u751f\u3002C. Propranolol \u70ba \u03b2 blocker\uff0c\u60f3\u4e0d\u5230\u5b83\u8ddf\u9aa8\u8cea\u758f\u9b06\u6703\u6709\u4ec0\u9ebc\u95dc\u806f\uff0cD. Glucocorticoid \u6703\u6291\u5236\u5728 osteoblast \u5167\u53d7 vitamin D3 \u8a98\u5c0e\u6d3b\u5316\u7684 osteocalcin gene\uff0c\u4ee5\u53ca\u8abf\u63a7 collagenase gene \u7684\u8f49\u9304\uff0c\u9020\u6210\u9aa8\u8cea\u758f\u9b06\u3002\n"}, {"id": "5592", "aimg": "0", "awall": "\nOxandrolone: testosterone & androgen \u7528\u4f86\u589e\u91cd\uff0c\u62ee\u6297\u985e\u56fa\u9187\u4f5c\u7528Desogestrel: \u9ec3\u9ad4\u7d20\u907f\u5b55\u85e5Anastrozole: Aromatase inh. \u964d\u4f4eEstrogen \u6cbb\u7642\u4e73\u764cFlutamide: \u00a0androgen-R blockor \u6cbb\u7642\u651d\u8b77\u817a\u764c\u6cbb\u7642\u651d\u8b77\u817a\u764cGnRH agonist//GnRH blockor\u00a0FSH ,LH\u4e0b\u964dLeuprolideGoserelin//abarelixGanirelix5a-reducatse inh.\u6291\u5236testosterone\u8f49DHT\u00a0Finasteride(\u67d4\u6c9b)Androgen-R blockor\u6291\u5236androgen bindingFlutamideCyproteroneSpironolactone*Androgen R blocker : \u4ed6\u5abd\u7684(-tamide)\u8105\u8feb\u4ed6\u4eba(cyproterone)\u771f\u4e0d\u914d\u7576\u7537\u4eba \u00a0(\u4f86\u81ea\u570b\u8003\u85e5\u8a23)\n"}, {"id": "5593", "aimg": "2806", "awall": "\n\u9752\u5149\u773c\u7528\u85e5A: \u03b1 agonist => epinephrine (\u773c\u85e5\u6c34)B: \u03b2 blocker => betaxololC: Cholinergic agonist => pilocarpine (\u773c\u85e5\u6c34)D: Diuretics => acetazolamideP: Prostaglandin => latanoprost, bimatoprostA. Atropine \u70ba anticholinergic agent\uff0c\u4e3b\u8981\u7528\u5728\u63a7\u5236\u8fd1\u8996\u7684\u6563\u77b3\u3002\u5982\u679c\u60a3\u8005\u6709 closed-angle glaucoma\uff0c\u5247\u8212\u5f35\u7684\u776b\u72c0\u808c\u53ef\u80fd\u6703\u963b\u7919\u623f\u6c34\u6d41\u51fa\uff0c\u4f7f\u9752\u5149\u773c\u767c\u4f5c\u3002B. Betaxolol \u70ba\u5730\u8868\u5730\u8868\u6700\u5f37\u3001\u6700\u9ad8\u9078\u64c7\u6027\u3001\u9ad8\u89aa\u548c\u529b\u7684 \u03b21 blocker\uff0c\u7528\u65bc\u6e1b\u5c11\u623f\u6c34\u5206\u6ccc\u3002C. Phentolamine \u70ba non-selective \u03b1 blocker\uff0c\u975c\u8108\u6ce8\u5c04\uff0c\u7528\u65bc\u75c5\u60a3\u4f4f\u9662\u6216\u958b\u5200\u6642\u8840\u58d3\u7dca\u6025\u98c6\u5347\uff0c\u6216\u662f\u88ab\u8840\u7ba1\u6536\u7e2e\u5291\u8aa4\u624e\u6642\u7684\u6025\u6551\u3002D. Tropicamide \u70ba anticholinergic agent\uff0c\u662f\u6700\u77ed\u6548\u7684\u6563\u77b3\u5291\uff0c\u7528\u65bc\u773c\u775b\u6aa2\u67e5\u524d\u7684\u6563\u77b3\u3002\n"}, {"id": "5594", "aimg": "2807", "awall": "\nA. Acetaminophen \u4e3b\u8981\u662f\u4f7f\u7528\u904e\u91cf\u6642\u7684\u809d\u6bd2\u6027\u3002B. \u5c0f\u5b69 + \u6d41\u611f + aspirin = Reye syndrome \u00a0\u8a18\uff01\uff01C. Sulindac \u70ba\u4e00\u7a2e NSAIDD. Ibuprofen \u70ba\u4e00\u7a2e NSAID\n"}, {"id": "5595", "aimg": "1428", "awall": "\nMAOI A=>for depression,phenelzine tranylcypromineMAOI B=>for Parkinson ,selegiline rasagiline\u00a0\n"}, {"id": "5596", "aimg": "0", "awall": "\n\u751f\u6d3b\u5c0f\u5e38\u8b58\u6240\u4ee5\u559d\u5047\u9152\u4e4b\u524d\u8981\u5728\u65c1\u908a\u5099\u4e00\u74f6\u771f\u7684 58 \u9ad8\u7cb1\n"}, {"id": "5597", "aimg": "0", "awall": "\nOpioid overdose triad\uff1aPinpoint pupils\u3001\u547c\u5438\u6291\u5236\u3001\u660f\u8ff7\n"}, {"id": "5598", "aimg": "2809", "awall": "\nA. Unithiol \u70ba\u91d1\u5c6c\u87af\u5408\u5291\uff0c\u7528\u4f86\u6cbb\u7642\u91cd\u91d1\u5c6c\u4e2d\u6bd2\u3002B. Dimercaprol \u7528\u4f86\u6cbb\u7642\u7837\u3001\u6c5e\u3001\u91d1\u53ca\u925b\u7684\u4e2d\u6bd2\u3002C. Succimer\uff08\u53c8\u53eb\u505a DSMA\uff09\uff0c\u7528\u4f86\u6cbb\u7642\u925b\u3001\u6c5e\u53ca\u7837\u7684\u4e2d\u6bd2\u3002D. D-dimethylcysteine \u53c8\u53eb\u505a penicillamide\uff0c\u70ba copper chelation agent\uff0c\u662f\u7528\u5728\u6cbb\u7642\u9285\u4e2d\u6bd2 (Wilson's desease)\u3002\u4f46\u7531\u65bc\u526f\u4f5c\u7528\u592a\u591a\uff0c\u76ee\u524d\u591a\u4ee5 zinc therapy \u53d6\u4ee3\u3002\u6839\u64daLANGE:penicillamide\u78ba\u5be6\u6709\u52a0\u901f\u6392\u9664\u6c5e\u7684\u6548\u679c\uff0c\u4f46\u4e0d\u5e38\u7528\uff1b\u6709\u6a5f\u6c5e\u7684\u6cbb\u7642\u53ea\u5beb\u4f7f\u7528BAL\u3001succimer\u3001EDTA\u3001unithiol \uff0c\u5c31\u662f\u6c92penicillamide\n"}, {"id": "5599", "aimg": "0", "awall": "\nA, D) Monoclonal antibody against EGFR\u00a0B) Tyrosine kinase inhibitor against EGFR\u00a0\n"}, {"id": "5600", "aimg": "0", "awall": "\nplerixafor \u70bahematopoietic stem cell mobilizer\uff0c\u8207\u9846\u7c92\u7403\u7fa4\u843d\u5f62\u6210\u523a\u6fc0\u56e0\u5b50(G-CSF)\u4e26\u7528\uff0c\u523a\u6fc0\u9020\u8840\u5e79\u7d30\u80de\u7531\u9aa8\u9ad3\u91cb\u653e\u5230\u5468\u908a\uff0c\u4f9b\u6536\u96c6\u4ee5\u65bd\u884c\u81ea\u9ad4\u79fb\u690d\u3002\u9069\u7528\u65bc\u8981\u505a\u81ea\u9ad4\u79fb\u690d\u7684non-Hodgskin's lymphoma\u6216\u662fmultiple myeloma\u7684\u75c5\u60a3\u3002Plerixafor\u00a0- Prevents the binding of stromal cell-derived factor-1\u03b1 (SDF-1\u03b1) to the CXCR4 chemokine receptor.\u00a0- Disrupts interaction between SDF-1\u03b1 and its receptor and interferes with retention of hematopoietic stem cells in bone marrow matrix.\u00a0-> Subsequently, increased numbers of CD34+ hematopoietic progenitor cells are mobilized or released from bone marrow, resulting in peripheral leukocytosis.\u00a0=> Mobilized CD34+ cells were then collected by apheresis and used as a stem-cell infusion to promote engraftment following high-dose chemotherapy associated with autologous stem-cell transplantation\u9020\u8840\u5e79\u7d30\u80de\u9a45\u52d5\u5291 plerixafor\r\n( Mozobil\u00ae\uff0c\u7e3d\u52d5\u539f\u6ce8\u5c04\u5291 )\uff0c\u662f\u4e00\u6f84\u6e05\u7121\u8272\u81f3\u6de1\r\n\u9ec3\u8272\u6ce8\u5c04\u6db2\uff0c\u53ef\u6291\u5236\u9020\u8840\u5e79\u7d30\u80de\u6216\u816b\u7624\u7d30\u80de\u4e4b CXC \r\nchemokine receptor 4 ( CXCR4 )\uff0c\u963b\u65b7 CXCR4 \u8207\u9aa8\u9ad3\r\n\u5167\u9aa8\u57fa\u8cea\u7d30\u80de\u4e4b stromal cell-derived factor-1-alpha \r\n( SDF-1\u03b1 ) \u9023\u7d50\uff0c\u4f7f\u767d\u8840\u7403\u7d30\u80de\u589e\u751f\u53ca\u5468\u908a\u8840\u9020\u8840\r\n\u5148\u9a45\u7d30\u80de\u589e\u52a0\u3002\u6240\u4ee5 plerixafor \u642d\u914d G-CSF \u53ef\u5354\u540c\r\n\u9a45\u52d5\u51fa\u8db3\u5920\u5e36\u6709 CD34+\u6297\u539f\u7684\u9020\u8840\u5e79\u7d30\u80de\uff0c\u4ee5\u4f9b\u79fb\r\n\u690d\u4e4b\u7528\u3002\u7531\u65bc\u88ab\u9a45\u52d5\u7684\u9020\u8840\u5e79\u7d30\u80de\u8868\u9762\u6709 CD34+\r\n\u6297\u539f\uff0c\u53ef\u7528\u6b64\u6a19\u8a8c\u5b9a\u91cf\u53ca\u8a08\u6578\u9020\u8840\u5e79\u7d30\u80de\uff0c\u4e5f\u53ef\u964d\r\n\u4f4e\u5fae\u91cf\u764c\u7d30\u80de\u6c61\u67d3\u53ef\u80fd\u6027\u3002\n"}, {"id": "5601", "aimg": "0", "awall": "\nA. Atezolizumab \u70ba anti-PD-L1\uff0c\u53ef\u6cbb\u7642 HCC\u3002B. Panitunumab \u70ba anti-EGFR\uff0c\u53ef\u6cbb\u7642\u5927\u8178\u764c\uff08KRAS \u7a81\u8b8a\u7121\u6548\uff09\u3001\u982d\u9838 SCCC. Ramucirumab \u70ba anti-VEGHR2\uff0c\u53ef\u6cbb\u7642\u9ad8 \u03b1-FP \u7684 HCC\u3002D. Rituximab \u70ba anti-CD20\uff0c\u53ef\u6cbb\u7642 non-Hodgkin B cell lymphoma\u3002\n"}, {"id": "5602", "aimg": "2812", "awall": "\n\u5e7e\u7a2e\u91cd\u8981\u65b0\u85e51.\u00a0Lomitapide: \u6291\u5236 microsomal triglyceride transfer protein (MTP)\u30022. Mipomersen: \u6291\u5236 ApoB-100\u30023.\u00a0Evolocumab\u3001Alirocumab: \u6291\u5236 PCSK9\u3002LDL\u672c\u8eab\u662f\u651c\u5e36\u5167\u6e90\u6027\u81bd\u56fa\u9187cholesterol\u7684\u4e3b\u529b(P.S.\u5916\u6e90\u6027\u81bd\u56fa\u9187+Triglyceride\u662fchylomicron\u4e73\u9e8b\u5fae\u7c92\u651c\u5e36)\u800c\u662fApoB-100\u662fLDL\u7528\u4f86\u555f\u7528\u80de\u98f2\u4f5c\u7528(\u651d\u5165/\u5403\u7684)\uff0c\u651d\u5165\u81bd\u56fa\u9187\u6545\u6291\u5236LDL\u7684\u91cf\u5c31\u80fd\u964d\u4f4e\u81bd\u56fa\u9187\n"}, {"id": "5603", "aimg": "0", "awall": "\nA. HMG-CoA reductase: StatinsB. ApoB-100: Mipomersen\u00a0C. Transport protein NPC1L1: EzetimibeD. Microsomal triglyceride transfer protein (MTP): Lomitapide\n"}, {"id": "5604", "aimg": "0", "awall": "\nMyositis ossificans : Soft tissue and muscle ossification (heterotopic ossification) can occur congenitally or after tissue or joint injuries or surgery.\u00a0EtiologyPost-traumatic: especially after implantation of an artificial\u00a0hip joint\u00a0and after\u00a0polytraumaNeurogenic: after nerve injuries,\u00a0meningitis, and\u00a0spinal cord injuriesChronic degenerative disease (e.g., in\u00a0ankylosing spondylitis)Muscle overuse (e.g., in athletes)\u9aa8\u5316\u6027\u808c\u708e\uff0c\u7c21\u55ae\u4f86\u8aaa\u5c31\u662f\u808c\u8089\u8b8a\u6210\u9aa8\u982d\u7b26\u5408\u5316\u751f\u7684\u5b9a\u7fa9\u539f\u4f86\u6b63\u5e38\u6210\u719f\u7684\u7d44\u7e54\u88ab\u53e6\u4e00\u7a2e\u4e0d\u6b63\u5e38\u4f46\u6210\u719f\u7684\u7d44\u7e54\u6240\u53d6\u4ee3\u3002(A) \u00a0\u7570\u751f(dysplasia):\u80da\u80ce\u767c\u80b2\u904e\u7a0b\u4e2d\uff0c\u7d30\u80de\u5728\u4e0d\u6b63\u78ba\u7684\u89e3\u5256\u4f4d\u7f6e\u5206\u5316\u751f\u9577(B) \u00a0\u589e\u751f(hyperplasia):\u56e0\u7d30\u80de\u6578\u76ee\u589e\u52a0\uff0c\u4f46\u7d30\u80de\u9ad4\u7a4d\u4e0d\u8b8a\uff0c\u9020\u6210\u5668\u5b98\u6216\u7d44\u7e54\u9ad4\u7a4d (\u91cd\u91cf)\u589e\u52a0(C) \u00a0\u840e\u7e2e(atrophy):\u56e0\u7d30\u80de\u6578\u76ee\u6e1b\u5c11\u6216\u7d30\u80de\u9ad4\u7a4d\u6e1b\u5c0f\uff0c\u9020\u6210\u5668\u5b98\u6216\u7d44\u7e54\u9ad4\u7a4d\u6e1b\u5c0f(D) \u00a0\u5316\u751f(metaplasia):\u539f\u4f86\u6b63\u5e38\u6210\u719f\u7684\u7d44\u7e54\u88ab\u53e6\u4e00\u7a2e\u4e0d\u6b63\u5e38\u4f46\u6210\u719f\u7684\u7d44\u7e54\u53d6\u4ee3\n"}, {"id": "5605", "aimg": "0", "awall": "\n(A) Russell body\uff1a\u6f3f\u7d30\u80de\u7684\u5167\u8cea\u7db2\u56e0\u70ba\u904e\u591a\u7684\u514d\u75ab\u7403\u86cb\u767d\u5408\u6210\u800c\u5145\u6eff\u514d\u75ab\u86cb\u767d\uff0c \u7a31\u4e4b\u70ba Russell body\uff0c\u5e38\u898b\u65bc\u591a\u767c\u6027\u9aa8\u9ad3\u7624\u00a0(B) Amyloid\uff1a\u985e\u6fb1\u7c89\u662f\u4e00\u7fa4\u7570\u8cea\u6027\u7684\u81f4\u75c5\u6027\u7e96\u7dad\u6027\u86cb\u767d\u8cea\uff0c\u5176\u53ef\u80fd\u56e0\u70ba\u5408\u6210\u904e\u591a \u6216\u662f\u7121\u6cd5\u4ee3\u8b1d\u800c\u5806\u7a4d\u5728\u7d44\u7e54\u6216\u8005\u5668\u5b98\u5167\u00a0(C) Mallory-Denk body\uff1a\u53c8\u7a31\u70ba mallory body\uff0c\u7531\u7d30\u80de\u9aa8\u67b6\uff08\u4e2d\u9593\u7d72\u9ad4\uff09\u6240\u69cb\u6210\uff0c \u5e38\u898b\u65bc\u9152\u7cbe\u6027\u809d\u708e\u00a0(D) Psammoma body\uff1a\u9223\u5316\u7403\uff0c\u53ef\u51fa\u73fe\u65bc\u5375\u5de2\u764c\u3001\u7532\u72c0\u817a\u764c\u3001\u8166\u819c\u7624\u7b49 \n"}, {"id": "5606", "aimg": "0", "awall": "\n\u57fa\u672c\u4e0a\u53ef\u60f3\u6210\u75c5\u6bd2\u9700\u8981\u7d93\u6297\u9ad4\u8abf\u7406\u4f5c\u7528\u88ab\u541e\u566c\u3002\u53ef\u53c3\u8003\u6b64\u6587\u737b\uff1aMamishi, S., Shahmahmoudi, S., Tabatabaie, H., Teimourian, S., Pourakbari, B., Gheisari, Y., ... & Parvaneh, N. (2008). Novel BTK mutation presenting with vaccine-associated paralytic poliomyelitis. European journal of pediatrics, 167(11), 1335-1338.\u00a0Bruton \u6c0f\u75c5(X-linked agammaglobulinemia [Bruton disease], XLA\uff09 \u4f4d\u65bc X \u67d3\u8272\u9ad4\u4e0a\u7684 Btk \u57fa\u56e0\u7f3a\u5931\u2192pre-B cell \u7121\u6cd5\u5206\u5316\u70ba\u6210\u719f B cell\u2192B cell \u6578\u91cf\u4e0d\u8db3\u2192\u7f3a\u4e4f\u6297\u9ad4\uff08=\u514d\u75ab\u7403\u86cb\u767d\uff09\u2192\u6f3f\u6db2\u6027\u514d\u75ab\u4e0b\u964d\u3002\u4e00\u822c\u4f86\u8aaa\u7d30\u80de\u514d\u75ab\u662f\u6b63\u5e38\u7684\uff0c\u56e0\u6b64\u5c0d\u65bc\u75c5\u6bd2\u3001\u9ef4\u83cc\u4ecd\u80fd\u6070\u7576\u8655\u7406\uff0c\u4f46\u6709\u5c11\u6578\u4f8b\u5916\uff0c\u4f8b\u5982\u6c99\u8cd3\u75ab\u82d7\u7684\u75c5\u6bd2\uff0c\u5728\u6b63\u5e38\u60c5\u6cc1\u4e0b\u6703\u88ab\u8840\u6db2\u4e2d\u7684\u6297\u9ad4\u4e2d\u548c\uff0c\u4f46\u662f\u6b64\u75be\u75c5\u60a3\u8005\u7f3a\u4e4f\u6297\u9ad4\uff0c\u56e0\u6b64\u6703\u5c0e\u81f4\u7671\u7613\u6027\u810a\u9ad3\u7070\u8cea\u708e\u7684\u767c\u751f\u3002A. DiGeorge syndrome\u53c8\u7a31\u70ba CATCH-22 syndromeC: cardiac abnormalityA: Abnormal faces \u6216 autoimmune \u554f\u984c\u554f\u984cT: T cell deficit owing to thymic hypoplasiaC: Cleft palateH: Hypocalcemia owing to hypoparathyroidism22: \u8b8a\u7570\u767c\u751f\u5728 chromosome 22C. Chronic granulomatous diseaseNeutrophils \u541e\u566c\u75c5\u539f\u5f8c\uff0c\u7121\u6cd5\u6709\u6548\u5c07\u5176\u6d88\u6ec5\uff0c\u800c\u7522\u751f\u7684\u75be\u75c5\u3002\u901a\u5e38\u662f\u56e0\u70ba NADPH oxidase \u6709\u554f\u984c\u800c\u7121\u6cd5\u7522\u751f reactive oxygen compounds\u3002D. Wiskott\u2013Aldrich syndrome (WAS) is a rare X-linked recessive disease characterized by eczema, thrombocytopenia (low platelet count), immune deficiency, and bloody diarrhea (secondary to the thrombocytopenia). It is also sometimes called the eczema-thrombocytopenia-immunodeficiency syndrome in keeping with Aldrich's original description in 1954.\n"}, {"id": "5607", "aimg": "0", "awall": "\nPAN \u7684\u98a8\u96aa\u56e0\u5b50\u6709 3 \u6210\u548c HBV \u611f\u67d3\u76f8\u95dc\uff0c\u4f46\u975e\u7531\u81ea\u9ad4\u514d\u75ab\u9020\u62101\u5c0b\u5e38\u578b\u5929\u76b0\u7621(pemphigus vulgaris)(\u4e00)\u00a0\u6a5f\u8f49:IgG \u5c0d\u6297\u81ea\u9ad4\u4e0a\u76ae\u7d30\u80de\u7684 desmogleins\uff0c\u5c0e\u81f4\u8868\u76ae\u4e0a\u76ae\u7d30\u80de\u9593\u7684\u9023\u7d50\u88ab\u7834\u58de\u800c\u5728\u8868\u76ae\u57fa\u5e95\u819c\u4ee5\u4e0a\u5f62\u6210\u6c34\u6ce1(suprabasal acantholyticblister)(\u4e8c)\u00a0\u5c6c\u65bc type II \u904e\u654f\u53cd\u61c92\u591a\u767c\u6027\u7d50\u7bc0\u6027\u52d5\u8108\u708e(polyarteritis nodosa)\u00a0(\u4e00) \u6a5f\u8f49:\u4e0d\u660e(\u4e8c)\u00a0\u5c6c\u65bc\u4e2d\u5c0f\u8840\u7ba1\u708e\uff0c30%\u7684\u75c5\u60a3 HBV(+)(\u4e09)\u00a0\u75c5\u7406:segmental transmural necrotizing inflammation companiedby fibrinoid necrosis\u00a03\u60e1\u6027\u8ca7\u8840(pernicious anemia)(\u4e00)\u00a0\u6a5f\u8f49:\u81ea\u9ad4\u6297\u9ad4\u7834\u58de\u80c3\u58c1\u7d30\u80de(parietal cell)\u5c0e\u81f4\u6c2b\u96e2\u5b50\u548c\u5167\u5728\u56e0\u5b50\u88fd\u9020 \u6e1b\u5c11\uff0c\u800c\u7f3a\u4e4f\u5167\u5728\u56e0\u5b50\u6703\u4f7f vit. B12 \u5438\u6536\u6e1b\u5c11\uff0c\u9020\u6210\u8ca7\u8840(\u4e8c)\u00a0\u81ea\u9ad4\u514d\u75ab\u53cd\u61c9\u4e5f\u6703\u5c0e\u81f4 type A \u6162\u6027\u80c3\u708e(\u840e\u7e2e\u6027\u80c3\u708e)\n"}, {"id": "5608", "aimg": "1659", "awall": "\nSmall Cell Carcinoma\u662fACTH\u8ddfADH\u591a\uff0c\u9020\u6210Cushing's Syndrome\u8ddfSIADH\n"}, {"id": "5609", "aimg": "2816", "awall": "\n(\u4e00)\u00a0TP53 \u57fa\u56e0\u6703\u8f49\u9304\u8f49\u8b6f\u51fa P53 \u6291\u764c\u86cb\u767d\uff0c\u8ca0\u8cac\u8abf\u63a7\u7d30\u80de\u9031\u671f\uff0c\u662f\u6240\u6709\u764c\u75c7\u76f8\u95dc \u57fa\u56e0\u4e2d\u6700\u6613\u7a81\u8b8a\u7684\uff0c\u7d04\u6709 50%\u7684\u764c\u75c7\u8207\u6b64\u57fa\u56e0\u7684\u7a81\u8b8a\u6709\u95dc\u4fc2\uff0c\u901a\u5e38\u9019\u4e9b\u764c\u7d30 \u80de\u4e2d\u7684\u5169\u500b TP53 \u7b49\u4f4d\u57fa\u56e0\u90fd\u6703\u51fa\u73fe\u7a81\u8b8a\uff0c\u800c\u9019\u7a81\u8b8a\u901a\u5e38\u662f\u5f8c\u5929\u6027\u7684\u3002(\u4e8c)\u00a0\u5728\u5c11\u6578\u60c5\u6cc1\u4e0b\uff0c\u75c5\u4eba\u6703\u81ea\u7236\u6bcd\u90a3\u907a\u50b3\u5230\u4e00\u500b\u7a81\u8b8a\u7684 TP53 \u57fa\u56e0\uff0c\u53ea\u8981\u53e6\u5916\u4e00 \u500b\u6b63\u5e38\u7684 TP53 \u7b49\u4f4d\u57fa\u56e0\u518d\u51fa\u73fe\u7a81\u8b8a\uff0c\u5c31\u53ef\u80fd\u6703\u7f79\u764c\uff0c\u9019\u4f7f\u5f97\u9019\u4e9b\u75c5\u4eba\u7684\u7f79\u764c \u6a5f\u6703\u5927\u5e45\u63d0\u5347\uff0c50 \u6b72\u524d\u5c31\u7f79\u764c\u7684\u6a5f\u7387\u662f\u6b63\u5e38\u4eba\u7684 25 \u500d\uff0c\u800c\u9019\u4e9b\u907a\u50b3\u5230\u7a81\u8b8a \u57fa\u56e0\u7684\u75c5\u60a3\u5c31\u6703\u6709\u6240\u8b02\u7684 Li-Fraumeni \u75c7\u5019\u7fa4\u3002(\u4e09)\u00a0Li-Fraumeni \u75c7\u5019\u7fa4\u75c5\u60a3\u7f79\u60a3\u7684\u764c\u75c7\u7a2e\u985e\u5dee\u5225\u5f88\u5927\uff0c\u6700\u5e38\u898b\u7684\u662f\u8089\u764c\u3001\u4e73\u764c\u3001 \u8840\u764c\u3001\u8166\u7624\u3001\u814e\u4e0a\u817a\u76ae\u8cea\u764c\u7b49\u7b49\uff0c\u9019\u4e00\u9ede\u548c two-hit hypothesis \u4e2d\u6700\u5e38\u898b\u7684\u4f8b \u5b50-RB gene \u4e0d\u540c\uff0cRB gene \u901a\u5e38\u53ea\u6703\u5c0e\u81f4\u8996\u7db2\u819c\u6bcd\u7d30\u80de\u7624\u6216\u9aa8\u8089\u764chttps://heho.com.tw/archives/32495WT-1 \u8ddfWilm's tumor(nephroblastoma)\u6709\u95dc\uff0c\u8a73\u60c5\u898b\u6ccc\u5c3f\u7cfb\u7d71\u75be\u75c5\u7684\u816b\u7624\u7bc7\n"}, {"id": "5610", "aimg": "0", "awall": "\nA. Churg-Strauss syndrome\uff0c\u53c8\u7a31 eosinophilic granulomatosis with polyangitis (EGPA)\uff0c\u820a\u7a31 allergic granulomatosis\uff0c\u5c0f\u52d5\u8108\u58c1\u4e0a\u53ca\u8840\u7ba1\u5916\u5f62\u6210 acute necrotizing granulomas\uff0c\u53ef\u4ee5\u770b\u5230\u767c\u708e\u7d30\u80de\u6d78\u6f64\uff0c\u4e14\u4ee5 eosinophil \u70ba\u4e3b\u3002\u5e38\u898b\u7684\u81e8\u5e8a\u75c7\u72c0\u5305\u62ec asthma\u3001eosinophil \u6d78\u6f64\u3001\u5468\u908a\u795e\u7d93\u75c5\u8b8a\u3001\u76ae\u75b9\u3002B. Polyateritis nodosa\uff0c\u5e38\u767c\u751f\u5728 young adult \u7684\u8178\u80c3\u9053\u3001\u809d\u3001\u814e\uff0c\u4e0d\u5f71\u97ff\u80ba\u5faa\u74b0\u3002 \u6709 30% \u7684\u8840\u6e05\u5448\u73fe HBsAg(+)\u3002HBsAg \u662f B \u578b\u809d\u708e\u8868\u9762\u6297\u539f\u3002\u5178\u578b\u75c7\u72c0\u5305\u62ec\u5feb\u901f\u60e1\u5316\u7684\u9ad8\u8840\u58d3\u3001\u8179\u75db\u3001\u8840\u4fbf\u3001\u5168\u8eab\u6027\u7684\u808c\u8089\u9178\u75db (diffuse myalgia)\u3001\u5468\u908a\u795e\u7d93\u75c5\u8b8a\u3002C. Buerger's disease = Thromboangiitis obliterans (\u8207\u62bd\u83f8\u76f8\u95dc & \u8207\u81ea\u9ad4\u514d\u75ab\u7121\u95dc)\u00a0 \u00a0 *Buerger's disease (\u963b\u585e\u6027\u8840\u6813\u6027\u8840\u7ba1\u708e) vs. Berger's disease (IgA nephropathy)D. Henoch-Sch\u00f6nlein purpura\uff0c\u5225\u7a31 anaphylactoid purpura\u3001IgA vasculitis nephritis\uff0c\u597d\u767c\u65bc 3-8 \u6b72\u5152\u7ae5\u3001young adult\uff0c\u9810\u5f8c\u826f\u597d\u3002\u8207\u5b63\u7bc0\u611f\u67d3\u76f8\u95dc\uff0c\u901a\u5e38\u5728 URI \u5f8c\u6709 IgA \u7522\u751f\uff0c\u51fa\u73fe\u809a\u5b50\u75db\u6216\u95dc\u7bc0\u75db\u7b49\u75c7\u72c0\u3002\n"}, {"id": "5611", "aimg": "0", "awall": "\n\u4e3b\u52d5\u8108\u9589\u9396\u660e\u986f\u6bd4\u7e2e\u7a84\u56b4\u91cd......\u53ef\u78ba\u5b9a\u7684\u662f\u4e2d\u8188\u7f3a\u640d\u985e\u7684\u75be\u75c5\u5e7e\u4e4e\u4e0d\u9700\u8981\u52d5\u8108\u5c0e\u7ba1\u4fdd\u6301\u958b\u653e\n"}, {"id": "5612", "aimg": "2817", "awall": "\n\u4e3b\u5c0e HD \u7684\u9810\u5f8c\u56e0\u7d20\u4e2d\uff0c\u4ecd\u4ee5\u5206\u671f (Ann Arbor classification) \u7684\u5f71\u97ff\u8f03\u5927\u4e14\u767c\u708e\u7d30\u80de>\u816b\u7624\u7d30\u80de\uff0c\u8f03\u5c11\u6dcb\u5df4\u5916\u4fb5\u72af\uff0c\u9810\u5f8c\u8f03\u597d(\u4ee5\u4e0a\u7686\u76f8\u5c0dnon-Hodgkin Lymphoma\u800c\u8a00)\u601d\u8003\u4e00\u4e0b Hodgkin lymphoma \u7684\u81f4\u75c5\u6a5f\u8f49\uff0c\u5c31\u662f\u4e00\u500b kh\u00edsi\u00e1u \u7684 tumor cell \u53eb\u505a RS cell\uff0c\u88ab\u4e00\u7fa4\u514d\u75ab\u7d30\u80de\u5718\u5718\u5305\u570d\uff0c\u4f46\u56e0\u70ba RS cell \u8868\u9762\u6709\u5404\u7a2e\u8b77\u8eab\u7b26\uff0c\u6240\u4ee5\u5468\u570d\u7684\u514d\u75ab\u7d30\u80de\u9762\u5c0d\u9019\u9846 kh\u00edsi\u00e1u \u7684\u7d30\u80de\u537b\u7121\u80fd\u70ba\u529b\uff0c\u90a3\u500b\u5834\u666f\u6eff\u597d\u7b11\u7684\u3002\u56e0\u6b64\uff0c\u5f88\u986f\u7136\u816b\u7624\u7d30\u80de\u53ea\u4f54\u5f88\u5c0f\u4e00\u90e8\u4efd\uff0c\u5176\u9918\u5927\u90e8\u4efd\u90fd\u662f\u6b63\u5e38\u7684\u514d\u75ab\u7d30\u80de\u3002\u6cbb\u7642\u7684\u8a71\uff0c\u53ea\u8981\u628a RS cell \u4e0a\u9762\u7684\u8b77\u8eab\u7b26\u7d66 block \u6389\uff0c\u4f8b\u5982 nivolumab \u628a PD-1 \u7d66 block \u4f4f\uff0c\u5c31\u80fd\u4f7f RS cell \u7684\u8b77\u8eab\u7b26\u5931\u6548\uff0c\u8b93\u5468\u570d\u7684\u514d\u75ab\u7d30\u80de\u53ef\u4ee5\u570d\u6bc6 tumor cell\uff0c\u6cbb\u7642\u6548\u679c\u5f88\u4e0d\u932f\u3002\u88dc\u5145: \u61c9\u8a72\u8840\u6db2\u5340\u6bb5\u6709\u5f37\u8abf B symptom \u548c\u9810\u5f8c\u5f88\u6709\u95dc\u4fc2(\u800c\u4e14HD\u9810\u5f8c\u53c8\u6bd4Non-HD\u597d)~~\u6240\u4ee5\u522a\u6389A\u3001D\n"}, {"id": "5613", "aimg": "0", "awall": "\n\u76ee\u524d\u9084\u6c92\u6709\u8a73\u89e3\u3002\n"}, {"id": "5614", "aimg": "0", "awall": "\nCOP\u7d44\u7e54\u6db2\u6d78\u6f64\u7a7a\u8154\u2192 \u963b\u585e\u2192 \u767c\u708e\u51fa\u73feMasson body\u4ee5Restrictive pulmonary disease\u5448\u73fe\u70ba\u4e3b\u6a5f\u5316\u6027\u80ba\u708e\u5c6c\u65bc\u9593\u8cea\u6027\u80ba\u708e\u7684\u4e00\u7a2e (\u5c0f\u652f\u6c23\u7ba1\u80ba\u708e\u5247\u662f\u6c23\u9053\u578b\u80ba\u708e)Cryptogenic organizing pneumonia: \u00a0histologically characterized by the presence of Masson bodies (granulation tissue buds made of foamy macrophages, mononuclear cells, and fibrous tissue) and Chronic patchy interstitial inflammation without fibrosis \u9019\u984c\u76f8\u4fe1\u591a\u6578\u4eba\u7684\u61c9\u8a72\u90fd\u4e0d\u6703\uff0c\u53ea\u80fd\u6191\u4e00\u9ede\u76f4\u89ba\u548c\u6280\u5de7\u731c\u984c\u3002\u7576\u521d\u53ea\u662f\u89ba\u5f97\u80ba\u708e \u4e0d\u6d89\u53ca\u5c0f\u652f\u6c23\u7ba1\u5be6\u5728\u6709\u9ede\u5947\u602a\uff08\u7562\u7adf\u80ba\u708e\u5c31\u662f\u4e0b\u547c\u5438\u9053\u611f\u67d3\u554a\uff09\uff0c\u6240\u4ee5\u5c31\u76f4\u89ba\u9078 (B)\u4e86\u3002\u76f4\u89ba\u5b9a\u52dd\u8ca0\uff0c\u8b9a\u8b9a\u3002\n"}, {"id": "5615", "aimg": "0", "awall": "\n\u80ba\u708e\u7684\u89e3\u5256\u5206\u985e\u6574\u7406\u5982\u4e0b\uff0c\u5176\u4e2d\u6c23\u9053\u6027(\u5178\u578b)\u9020\u6210\u6c23\u9053\u5be6\u8cea\u5316\uff0c\u9593\u8cea\u6027(\u975e\u5178\u578b) \u4fb5\u72af\u80ba\u6ce1\u58c1\u53ca\u9593\u8cea\uff0c\u4e0d\u6703\u6709\u6c23\u9053\u5be6\u8cea\u5316\u6c23\u9053\u6027\u5927\u8449\u6027\u80ba\u708e\u96d9\u7403\u83cc\u3001\u514b\u96f7\u4f2f\u6c0f\u83cc\u5c0f\u8449\u6027\u683c\u862d\u6c0f\u9670\u6027\u687f\u83cc\u3001\u91d1\u9ec3\u8461\u8404\u7403\u83cc\u9593\u8cea\u6027\u9ef4\u6f3f\u83cc\u3001\u75c5\u6bd2\u3001\u62ab\u8863\u83cc\u3001\u7acb\u514b\u6b21\u9ad4\u3001\u80ba\u56ca\u539f\u87f2\n"}, {"id": "5616", "aimg": "0", "awall": "\n\u5206\u985e\u8209\u4f8bObstruction\u3001Resorption\u75f0\u3001\u816b\u7624Compression\u6c23\u80f8\u3001\u808b\u819c\u7a4d\u6c34MicroatelectasisSurfactant\u4e0d\u8db3Contraction\u7e96\u7dad\u5316\n"}, {"id": "5617", "aimg": "0", "awall": "\n\u8a18\u5f97\u809d\u81df\u7e96\u7dad\u5316\u9760Space of Disse\u88e1\u7684Ito cell\u8f49\u8b8a\u800c\u4f86\uff0c\u6240\u4ee5\u5f9eSpace of Disse\u958b\u59cb\u7e96\u7dad\u5316\uff0c\u800cSpace of Disse\u9760\u8fd1Central veinA normal AST:ALT ratio should be <1. In patients with alcoholic liver disease, the AST:ALT ratio is >1 in 92% of patients, and >2 in 70%.13 AST:ALT scores >2 are, therefore, strongly suggestive of alcoholic liver disease and scores <1 more suggestive of NAFLD/NASH. (Hall P, Cash J. What is the real function of the liver 'function' tests? Ulster Med J. 2012 Jan;81(1):30-6. PMID: 23536736; PMCID: PMC3609680. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609680/ )\n"}, {"id": "5618", "aimg": "0", "awall": "\nbeta-catenin activated adenoma\u75c5\u7406\u4e0a\u8207 HCC \u76f8\u8fd1\uff0c\u60e1\u6027\u5316\u98a8\u96aa\u9ad8(B) HNF1-\u03b1 Inactivated hepatocellular adenomas HNF1-\u03b1 \u662f transcription factor\uff0c\u5728 beta cell \u7684\u5206\u5316\u626e\u6f14\u91cd\u8981\u7684\u89d2\u8272\u3002HNF1- \u03b1 \u7684\u7a81\u8b8a\u6703\u9020\u6210 MODY 3(maturity onset diabetes of the young, type 3). MODY 3 \u7684\u60a3\u8005\u82e5\u540c\u6642\u7f79\u60a3 hepatocellular adenomas \uff0c\u4ee3\u8868 HNF1- \u03b1 \u767c\u751f \u4e86\u4e8c\u6b21\u7a81\u8b8a\u3002\u00a0(C) \u03b2-Catenin activated hepatocellular adenomas \u03b2-catenin \u662f oncogene\uff0c\u5176\u7a81\u8b8a\u8207\u8a31\u591a\u5668\u5b98\u7684\u764c\u75c7\u6709\u95dc\u3002\u5c31\u809d\u81df\u800c\u8a00\uff0c\u5b83\u6240\u9020 \u6210\u7684 hepatocellular adenomas \u6709\u6975\u9ad8\u5ea6\u98a8\u96aa\u8f49\u6210\u60e1\u6027\u816b\u7624\uff0c\u56e0\u6b64\u5373\u4f7f\u6c92\u6709 \u75c7\u72c0\u4e5f\u9700\u8981\u88ab\u5207\u9664\u3002\u00a0(D)Inflammatory hepatocellular adenomas \u8a72\u817a\u764c\u7684\u7279\u5fb5\u662f gp130 \u7684 activating mutation\u3002Gp130 \u662f IL-6 \u7684 coreceptor\uff0c\u662f\u69cb\u6210 JAK-STAT signaling \u7684\u4e00\u90e8\u4efd\uff0c\u6700\u7d42\u6703\u4fc3\u9032\u7cfb\u7d71\u6027\u7684\u767c\u708e\u53cd \u61c9\uff0c\u56e0 \u6b64 \u9019 \u7a2e \u817a \u764c \u88ab \u6b78 \u985e \u6210 \u514d \u75ab \u6027 \u817a \u764c \u3002 Inflammatory hepatocellular adenomas \u6709\u4e00\u5b9a\u7684\u98a8\u96aa\u6703\u8f49\u70ba\u60e1\u6027\uff0c\u56e0\u6b64\u53ef\u80fd\u9700\u8981\u5728\u6c92\u75c7\u72c0\u6642\u5c31\u8981\u4e88\u4ee5\u5207 \u9664\u300210%\u7684 inflammatory hepatocellular adenomas \u6703\u4f34\u96a8\u6709 \u03b2-catenin activating mutations\uff0c\u9019\u985e\u764c\u75c7\u6703\u6709\u66f4\u9ad8\u7684\u98a8\u96aa\u8f49\u70ba\u60e1\u6027\u3002\u767c\u751f\u7387\u6027\u5225\u7d44\u7e54\u5b78\u7279\u5fb5\u764c\u8b8a\u98a8\u96aa\u76f8\u95dc\u56e0\u5b50HNF1-alpha Inactivated\u00a040%F\u8102\u80aa\u8b8a\u6027\u7121MODY3Inflammatory50%F/M\u767c\u708e\u7d30\u80de\u6d78\u6f64\u4f4egp130 (IL-6 R)\u03b2-catenin activated10%F/M\u975e\u5178\u578b\u7d30\u80de\u9ad8\u03b2-catenin\n"}, {"id": "5619", "aimg": "0", "awall": "\n\u80c3\u6ccc\u7d20\uff08gastrin\uff09\u5206\u6ccc\u589e\u52a0\uff0c\u56e0\u6b64\u53ef\u63a8\u6e2c\u80c3\u7ac7\uff08antrum\uff09G cell \u4e5f\u6703\u589e\u52a0\u4fc3\u9032\u5176\u5206\u6ccc\n"}, {"id": "5620", "aimg": "10040", "awall": "\nlow-grade papillary UC\uff1aFGFR3 (low-stage non-invasive), HRAS\u7b49 oncogene \u7372\u5f97\u76f8\u95dc (mutate activate -> Hyperplasia)high-grade papillary UC\uff1aRb1, TP53 (carcinoma-in-situ CIS -> late-stage invasive carcinoma) \u7b49 tumor surpressor gene \u7f3a\u5931DNA repair \u76f8\u95dc (Dysplasia and apoptosis, instable genome)ps. \u9019\u984c\u5efa\u8b70\u53c3\u8003\u5373\u53ef\uff0c\u8003\u8a66\u61c9\u8a72\u5f88\u96e3\u6e96\u5099\u5230\u9019\u984c\uff0c\u5c31\u9023\u75c5\u7406\u8056\u7d93 Robbins \u4e5f\u6c92\u63d0\u5230 \u9019\u9ebc\u7d30\uff0c\u5e73\u5e38\u591a\u71d2\u9999\u62dc\u62dc\u4fdd\u4f51\u4f5c\u7b54\u6642\u80fd\u731c\u5c0d\u53ef\u80fd\u9084\u6bd4\u8f03\u6709\u7528\u4e00\u9ede\u3002\n"}, {"id": "5621", "aimg": "0", "awall": "\n\u6069\uff0c\u9019\u984c\u2026.\u6191\u73fe\u6709\u77e5\u8b58\u4e5f\u4e0d\u77e5\u9053\u600e\u9ebc\u731c\uff0c\u679c\u65b7\u653e\u68c4 \u7ffb\u4e86\u4e00\u4e0b\u8001\u8d99\u75c5\u7406\u4e5f\u6c92\u6709\u8b1b\uff0c\u9047\u5230\u5c31\u76f4\u63a5\u9001\u4ed6\u3105 \u8a73\u89e3 (\u6709\u7a7a\u518d\u770b\uff0c\u76f4\u63a5\u80cc\u7b54\u6848\u6bd4\u8f03\u5feb)\u00a0\u7d93\u7814\u7a76\u767c\u73fe\uff0cM \u578b\u7684 phospholipase A2 \u53d7\u9ad4\uff0c\u4e00\u7a2e\u5927\u91cf\u8868\u73fe\u65bc\u7d72\u7403\u9ad4\u8db3\u7d30\u80de\u7684 \u7a7f\u819c\u86cb\u767d\uff0c\u88ab\u8a8d\u5b9a\u70ba\u539f\u767c\u6027\u819c\u884c\u814e\u75c5\u8b8a\u4e2d\u7684\u4e3b\u8981\u6297\u539f, anti-phospholipase A2 antibody is IgG4 \u3002Secandary MN \u5247\u70ba IgG 1, 2, 3Ref: Robbins 10th edMembranous nephropathy is caused by an autoimmune response, most often directed against the PLA2R on podocytes.Granular subepithelial deposits of antibodies with GBM thickening and loss of foot processes but no inflammationA subclass of IgG, IgG4, which differs from other IgG subclasses in being a poor activator of the classical complement pathway, is the principle Ig deposited in most classes of membranous neuropathy.How IgG4 may activate the complement system is not clear.\n"}, {"id": "5622", "aimg": "0", "awall": "\nGranulomatous thyroiditis \u901a\u5e38\u662f\u5148\u6709\u4e0a\u547c\u5438\u9053\u75c5\u6bd2\u611f\u67d3\uff08URI\uff09\uff0c\u6703\u523a\u6fc0 Tc cell \u4f86\u6e05\u9664 infection\uff0c\u4f46\u53ef\u80fd follicular cell \u4e0a\u5e36\u6709\u76f8\u4f3c\u7684 antigen \u800c\u88ab\u9019\u4e9b Tc cell \u8fa8\u8a8d \u5230\uff0c\u56e0\u6b64\u9020\u6210 follicular cell damage\u3002\n"}, {"id": "5623", "aimg": "0", "awall": "\n8q24 deletion\u8ddf\u9aa8\u982d\u751f\u9577\u7de9\u6162\u6bd4\u8f03\u6709\u95dc\u8003\u9019\u500b\u5230\u5e95\u662fWTF\n"}, {"id": "5624", "aimg": "0", "awall": "\nyolk salk tumor \u5728\u6210\u4eba\u591a\u70bamixed germ cell tumor\u7684\u4e00\u90e8\u5206\uff0c\u82e5\u70ba\u5e7c\u7ae5\u6216\u5b30\u5152\u5247\u5e38\u55ae\u7368\u767c\u751f\n"}, {"id": "5625", "aimg": "0", "awall": "\nCIN1 = \u53d6\u4ee3\u4e0a\u76ae\u4e0b 1/3CIN2 = \u53d6\u4ee3\u4e0a\u76ae\u4e0b 2/3CIN3 = \u53d6\u4ee3\u4e0a\u76ae\u4e0b > 2/3~\u6574\u5c64\n"}, {"id": "5626", "aimg": "0", "awall": "\n(A) \u932f\u8aa4\uff0c\u767c\u80b2\u4e0d\u826f\u75e3\u7684\u5927\u5c0f\u6703\u5927\u65bc 5mm\u3002\u767c\u80b2\u4e0d\u826f\u75e3\u7684\u8a3a\u65b7\u689d\u4ef6\u9808\u7b26\u5408\u4ee5\u4e0b\u4e94 \u9ede\u4e2d\u7684\u4e09\u9ede\u4ee5\u4e0a\uff1a(1)\u5206\u754c\u4e0d\u6e05\u3001(2)\u5927\u5c0f>5mm\u3001(3)\u96dc\u8272\u3001(4)\u51f9\u51f8\u4e0d\u5e73\u3001(5)\u7d05\u6591\u3002\u00a0(B) \u932f\u8aa4\uff0c\u767c\u80b2\u4e0d\u826f\u75e3\u53ef\u4ee5\u51fa\u73fe\u5728\u4efb\u4f55\u5730\u65b9\uff0c\u4f46\u662f\u7537\u6027\u8f03\u5bb9\u6613\u51fa\u73fe\u5728\u8ec0\u5e79\uff0c\u800c\u5973\u6027 \u8f03\u5bb9\u6613\u51fa\u73fe\u5728\u5c0f\u817f\u4e0a\u3002\u00a0(C) \u932f\u8aa4\uff0c\u76ae\u5167\u75e3\u8ddf\u767c\u80b2\u4e0d\u826f\u75e3\u5728\u75e3\u7684\u5206\u985e\u4e0a\u5c6c\u65bc\u4e0d\u540c\u7684\u5169\u7fa4\uff0c\u76ae\u5167\u75e3\u662f\u6307\u75e3\u53ea\u5b58 \u5728\u65bc dermis \u88e1\u9762\uff0c\u800c\u6c92\u6709\u5230\u9054 epidermis\u3002\u00a0(D)\u6b63\u78ba\uff0c\u96d6\u7136\u767c\u80b2\u4e0d\u826f\u75e3\u76f8\u8f03\u65bc\u4e00\u822c\u7684\u75e3\u4f86\u8aaa\u6709\u66f4\u9ad8\u7684\u6a5f\u7387\u6703\u8b8a\u6210\u9ed1\u8272\u7d20\u7624\uff0c\u4f46 \u7d55\u5927\u90e8\u5206\u7684\u767c\u80b2\u4e0d\u826f\u75e3\u90fd\u9084\u662f\u4e0d\u6703\u8f49\u6210\u9ed1\u8272\u7d20\u7624\u3002 \n"}, {"id": "5627", "aimg": "0", "awall": "\nPsoriasis\u75c7\u72c0 : \u754c\u7dda\u6e05\u695a\u7d05\u8272\u4e18\u75b9\uff0c\u8868\u9762\u9280\u7070\u8272\u812b\u5c51\uff0c\u597d\u767c\u4f38\u5074\u75c5\u7406 : \u589e\u539a\u89d2\u8cea\u5c64\u542b\u6838\u7d30\u80de\u6b98\u9ab8 (parakeratosis)\uff0cMunro microabcess\uff0cAcanthosis*\u4e00\u822c\u89d2\u8cea\u5c64\u7d30\u80de\u56e0\u70ba\u89d2\u5316\uff0c\u6703\u81ea\u5df1\u6b7b\u6389\u3002\u984c\u76ee\u63d0\u793a\u89d2\u5316\u4e0d\u5168\uff0c\u53ef\u4ee5\u63a8\u8ad6\u7d30\u80de\u672a\u5206\u5316\u5b8c\u5168\uff0c\u6240\u4ee5\u4fdd\u7559\u6838\n"}, {"id": "5628", "aimg": "0", "awall": "\n\u4e9e\u6025\u6027\u810a\u9ad3\u806f\u5408\u9000\u5316(Subacute combined degeneration of spinal cord)\uff0c\u53c8\u7a31\u70ba Lichtheim's disease\uff1a\u810a\u9ad3\u5f8c\u67f1\u8207\u5074\u7d22\u4e4b\u53bb\u9ad3\u9798\u8b8a\u5316\uff0c\u5c0e\u81f4\u611f\u89ba\u7570\u5e38Ref: Robbins 10th edCNS lesions: 75% of florid pernius anemiaThe principle alternations involve the cord, where there is demyelination of the dorsal and lateral spinal tracts, sometimes followed by loss of axonsSpastic paraparesis, Sensory ataxia, Severe paresthesias in the lower limbsVit B12 deficiency: subacute combined degeneration of the spinal cord, marked by degeneration of the ascending and descending spinal tracts.\n"}]